<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">63745</article-id><article-id pub-id-type="doi">10.7554/eLife.63745</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Perinatal granulopoiesis and risk of pediatric asthma</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-210007"><name><surname>Turturice</surname><given-names>Benjamin A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9382-4612</contrib-id><email>bturtu2@uic.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210167"><name><surname>Theorell</surname><given-names>Juliana</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210168"><name><surname>Koenig</surname><given-names>Mary Dawn</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210169"><name><surname>Tussing-Humphreys</surname><given-names>Lisa</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210170"><name><surname>Gold</surname><given-names>Diane R</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210171"><name><surname>Litonjua</surname><given-names>Augusto A</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210172"><name><surname>Oken</surname><given-names>Emily</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210173"><name><surname>Rifas-Shiman</surname><given-names>Sheryl L</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-207812"><name><surname>Perkins</surname><given-names>David L</given-names></name><email>perkinsd@uic.edu</email><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-210174"><name><surname>Finn</surname><given-names>Patricia W</given-names></name><email>pwfinn@uic.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Microbiology and Immunology, University of Illinois</institution><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Department of Medicine, Division of Pulmonary, Critical Care, Sleep, and Allergy, University of Illinois</institution><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Department of Women, Children and Family Health Science, College of Nursing, University of Illinois</institution><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Department of Medicine and Cancer Center, University of Illinois</institution><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>Department of Environmental Health, Harvard T.H. Chan School of Public Health</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution>Division of Pulmonary Medicine, Department of Pediatrics, University of Rochester</institution><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution>Division of Chronic Disease Research Across the Life Course, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution>Department of Medicine, Division of Nephrology, University of Illinois</institution><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff10"><label>10</label><institution>Department of Bioengineering, University of Illinois</institution><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="senior_editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Senior Editor</role><aff><institution>Icahn School of Medicine at Mount Sinai</institution><country>United States</country></aff></contrib><contrib contrib-type="editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Reviewing Editor</role><aff><institution>Icahn School of Medicine at Mount Sinai</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>10</day><month>02</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e63745</elocation-id><history><date date-type="received" iso-8601-date="2020-10-05"><day>05</day><month>10</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-02-05"><day>05</day><month>02</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Turturice et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Turturice et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-63745-v2.pdf"/><abstract><p>There are perinatal characteristics, such as gestational age, reproducibly associated with the risk for pediatric asthma. Identification of biologic processes influenced by these characteristics could facilitate risk stratification or new therapeutic targets. We hypothesized that transcriptional changes associated with multiple epidemiologic risk factors would be mediators of pediatric asthma risk. Using publicly available transcriptomic data from cord blood mononuclear cells, transcription of genes involved in myeloid differentiation was observed to be inversely associated with a pediatric asthma risk stratification based on multiple perinatal risk factors. This gene signature was validated in an independent prospective cohort and was specifically associated with genes localizing to neutrophil-specific granules. Further validation demonstrated that umbilical cord blood serum concentration of PGLYRP-1, a specific granule protein, was inversely associated with mid-childhood current asthma and early-teen FEV<sub>1</sub>/FVCx100. Thus, neutrophil-specific granule abundance at birth predicts risk for pediatric asthma and pulmonary function in adolescence.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>asthma</kwd><kwd>peptidoglycan recognition protein</kwd><kwd>granulocytes</kwd><kwd>fetal blood</kwd><kwd>risk factor</kwd><kwd>allergy</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>F30HL136001</award-id><principal-award-recipient><name><surname>Turturice</surname><given-names>Benjamin A</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R01AI053878</award-id><principal-award-recipient><name><surname>Finn</surname><given-names>Patricia W</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009633</institution-id><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution></institution-wrap></funding-source><award-id>R01HD034568</award-id><principal-award-recipient><name><surname>Oken</surname><given-names>Emily</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>UH3OD023286</award-id><principal-award-recipient><name><surname>Oken</surname><given-names>Emily</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000867</institution-id><institution>Robert Wood Johnson Foundation</institution></institution-wrap></funding-source><award-id>Nurse Faculty Scholars Program #72117</award-id><principal-award-recipient><name><surname>Koenig</surname><given-names>Mary Dawn</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008522</institution-id><institution>University of Illinois at Chicago</institution></institution-wrap></funding-source><award-id>College of Nursing Dean's Award</award-id><principal-award-recipient><name><surname>Koenig</surname><given-names>Mary Dawn</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Perinatal granulopoiesis and cord blood serum PGLYRP-1, a specific granule protein, are altered prior to onset of childhood asthma and provide potential targets for early identification of at-risk populations.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Several risk factors for pediatric asthma can be ascertained in the perinatal period. These risk factors include maternal characteristics (e.g., maternal atopy, maternal body mass index [BMI], race/ethnicity), demographics (e.g., newborn sex), and birth characteristics (e.g., birthweight, gestational age at birth, mode of delivery) (<xref ref-type="bibr" rid="bib2">Bisgaard and Bønnelykke, 2010</xref>). Meta-analyses have provided strong evidence for associations between the variables stated above and risk for pediatric asthma (<xref ref-type="bibr" rid="bib19">Jaakkola et al., 2006</xref>; <xref ref-type="bibr" rid="bib37">Mu et al., 2014</xref>; <xref ref-type="bibr" rid="bib59">Thavagnanam et al., 2008</xref>; <xref ref-type="bibr" rid="bib71">Xu et al., 2014</xref>). Many of these risk factors co-occur (e.g., low birthweight and preterm birth), and it has yet to be discerned whether their imparted risk is mediated through similar biologic processes.</p><p>Meta-analyses assessing peripheral blood leukocytes of school-aged children have identified differentially methylated regions proximal, or within, genes specifically transcribed in eosinophils as a common signature in pediatric asthma (<xref ref-type="bibr" rid="bib72">Xu et al., 2018</xref>; <xref ref-type="bibr" rid="bib46">Reese et al., 2019</xref>). These findings are consistent with observations of enhanced T2 inflammatory responses in children with asthma (<xref ref-type="bibr" rid="bib69">Wenzel, 2012</xref>). However, when assessing cord blood mononuclear cell (CBMC) samples, differential methylation did not extend to these and other classically T2-associated loci (<xref ref-type="bibr" rid="bib46">Reese et al., 2019</xref>). Interestingly, some individuals are predisposed at birth to generating T2 responses ex vivo to common asthma triggers (e.g. aeroallergens) or having detectable IgE concentrations in cord blood but neither has been shown to predict asthma later in life (<xref ref-type="bibr" rid="bib51">Schaub et al., 2005</xref>; <xref ref-type="bibr" rid="bib62">Turturice et al., 2017a</xref>; <xref ref-type="bibr" rid="bib53">Shah et al., 2011</xref>). These findings are suggestive of limited prognostication in asthma risk provided by the variation in T2 immunity at birth. Additionally, efforts aimed at modulating immunity in utero and through early life (e.g. vitamin D, probiotics) have failed to demonstrate benefit in the prevention of asthma (<xref ref-type="bibr" rid="bib28">Litonjua et al., 2020</xref>; <xref ref-type="bibr" rid="bib1">Azad et al., 2013</xref>). Further investigation is required to understand the aspects of newborn immunity associated with pediatric asthma.</p><p>The neonatal immune system undergoes many developmental changes throughout gestation and early life. Throughout the majority of gestation, fetal hematopoiesis generates mainly lymphoid and erythroid lineages. While the bone marrow capacity to produce all cell lineages increases toward term gestation, the ability to produce myeloid lineages is most pronounced in later gestational ages (<xref ref-type="bibr" rid="bib11">Forestier et al., 1991</xref>; <xref ref-type="bibr" rid="bib15">Glasser et al., 2015</xref>). Further highlighting the unique immunology of the perinatal time period, there are cell populations (e.g. CXCL8-producing T cells, myeloid-derived suppressor cells) that are highly abundant in cord blood that are rapidly depleted over the first week (<xref ref-type="bibr" rid="bib14">Gibbons et al., 2014</xref>; <xref ref-type="bibr" rid="bib39">Olin et al., 2018</xref>; <xref ref-type="bibr" rid="bib48">Rieber et al., 2013</xref>). Importantly, in utero factors, such as preterm birth and gestational hypertension, can impact perinatal hematopoiesis. These events can impair neutrophil abundance and function at birth but return to adult levels within days of birth similar to that of those who did not have such an exposure (<xref ref-type="bibr" rid="bib15">Glasser et al., 2015</xref>; <xref ref-type="bibr" rid="bib39">Olin et al., 2018</xref>; <xref ref-type="bibr" rid="bib52">Schmutz et al., 2008</xref>). This highlights great variability in the early-life hematopoietic composition driven by in utero differences that rapidly converges to a new baseline as the neonates adapts to its new environment.</p><p>This variability in immunity the perinatal time period might be reflective of the presence of multiple risk factors for asthma and facilitate a more detailed risk stratification and, ultimately, identification of potential therapeutic targets. Our focus was to determine biologic processes – extending to both transcriptional and serologic levels – associated with pediatric asthma risk that are detectable at birth. We hypothesized that transcriptional changes in CBMCs associated with multiple epidemiologic risk factors would be mediators of pediatric asthma risk. CBMCs have been previously studied with regards to cytokine production, DNA methylation, and outcomes (<xref ref-type="bibr" rid="bib46">Reese et al., 2019</xref>; <xref ref-type="bibr" rid="bib62">Turturice et al., 2017a</xref>; <xref ref-type="bibr" rid="bib27">Lin et al., 1993</xref>; <xref ref-type="bibr" rid="bib33">Ly et al., 2007</xref>; <xref ref-type="bibr" rid="bib64">Turturice et al., 2019</xref>; <xref ref-type="bibr" rid="bib7">den Dekker et al., 2019</xref>), making them ideal candidates for investigation. Here, we identify a novel association between epidemiologic risk, neutrophil-specific granules, and pediatric pulmonary outcomes including childhood asthma.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Approach to identify immunologic differences associated with risk for pediatric asthma</title><p>We developed an analytic approach to identify genes whose expression in CBMCs are associated with newborns with higher or lower risk for asthma. We conducted a meta-analysis to increase power and generalizability (<xref ref-type="fig" rid="fig1">Figure 1A,B</xref>). In our approach, we queried NCBI’s Gene Expression Omnibus for CBMC microarray datasets that included metadata regarding the demographics and birth characteristics that are risk factors for pediatric asthma. We identified 354 datasets from our original search, of which 17 datasets contained relevant metadata. Of the 17 studies, the most common maternal and neonatal characteristics reported were newborn sex, gestational age at birth, birthweight, and maternal pre-pregnancy BMI (PP BMI) at 69.96%, 51.59%, 30.27%, and 19.32% of samples, respectively. Metadata regarding maternal smoking and mode of delivery (i.e., vaginal vs. cesarean section) was reported for three datasets; however, two of these datasets originated from the same laboratory group and contributed the majority of samples reporting these factors. None of the identified datasets reported metadata about maternal atopy or child’s ethnicity. Therefore, we chose to focus the analysis on gene expression associated with newborn sex, gestational age at birth, newborn weight, and maternal PP BMI. Six datasets were excluded due to homogenous metadata (e.g., all female). Datasets and the corresponding analysis are reported; a total of 605 unique transcriptomes were included (<xref ref-type="table" rid="table1">Table 1</xref>; <xref ref-type="bibr" rid="bib5">Bukowski et al., 2017</xref>; <xref ref-type="bibr" rid="bib10">Edlow et al., 2016</xref>; <xref ref-type="bibr" rid="bib21">Kallionpää et al., 2014</xref>; <xref ref-type="bibr" rid="bib34">Mason et al., 2010</xref>; <xref ref-type="bibr" rid="bib44">Rager et al., 2014</xref>; <xref ref-type="bibr" rid="bib54">Smith et al., 2014</xref>; <xref ref-type="bibr" rid="bib56">Stünkel et al., 2012</xref>; <xref ref-type="bibr" rid="bib61">Turan et al., 2012</xref>; <xref ref-type="bibr" rid="bib66">Votavova et al., 2011</xref>; <xref ref-type="bibr" rid="bib67">Votavova et al., 2012</xref>; <xref ref-type="bibr" rid="bib70">Winckelmans et al., 2017</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Overview of analytic approach used to identify biological risk for pediatric asthma.</title><p>(<bold>A</bold>) Previously described perinatal risk factors for development of pediatric asthma: preterm birth, low birthweight, male, and maternal obesity. (<bold>B</bold>) Flow diagram of search, inclusion, exclusion, and univariate testing for transcriptomic analysis. (<bold>C</bold>) Cohorts, types of biosamples, and outcomes used for validation.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63745-fig1-v2.tif"/></fig><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>GSE data sets used for meta-analyses.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>GSE</th><th>GPL</th><th>N</th><th>Newborn sex</th><th>Gestational age</th><th>Birthweight</th><th>Maternal pre-pregnancy BMI</th><th>Title</th></tr></thead><tbody><tr><td>GSE21342</td><td>GPL6947</td><td>37</td><td/><td/><td/><td><bold>+</bold></td><td>Maternal influences on the transmission of leukocyte gene expression profiles in population samples</td></tr><tr><td>GSE25504</td><td>GPL570</td><td>20</td><td><bold>+</bold></td><td/><td/><td/><td>Whole blood mRNA expression profiling of host molecular networks in neonatal sepsis</td></tr><tr><td>GSE27272</td><td>GPL6883</td><td>64</td><td/><td><bold>+</bold></td><td><bold>+</bold></td><td><bold>+</bold></td><td>Comprehensive study of tobacco smoke-related transcriptome alterations in maternal and fetal cells</td></tr><tr><td>GSE30032</td><td>GPL6883</td><td>47</td><td/><td><bold>+</bold></td><td><bold>+</bold></td><td><bold>+</bold></td><td>Deregulation of gene expression induced by environmental tobacco smoke exposure in pregnancy</td></tr><tr><td>GSE36828</td><td>GPL6947</td><td>48</td><td/><td><bold>+</bold></td><td><bold>+</bold></td><td/><td>Genome-wide analysis of gene expression levels in placenta and cord blood samples from newborns babies</td></tr><tr><td>GSE37100</td><td>GPL14550</td><td>38</td><td><bold>+</bold></td><td><bold>+</bold></td><td><bold>+</bold></td><td/><td>Transcriptome changes affecting hedgehog and cytokine signaling in the umbilical cord in late pregnancy: implications for disease risk</td></tr><tr><td>GSE48354</td><td>GPL16686</td><td>38</td><td><bold>+</bold></td><td><bold>+</bold></td><td><bold>+</bold></td><td/><td>Prenatal arsenic exposure and the epigenome: altered gene expression profiles in newborn cord blood</td></tr><tr><td>GSE53473</td><td>GPL13667</td><td>128</td><td><bold>+</bold></td><td><bold>+</bold></td><td/><td/><td>Standard of hygiene and immune adaptation in newborn infants</td></tr><tr><td>GSE60403</td><td>GPL570</td><td>16</td><td><bold>+</bold></td><td/><td/><td><bold>+</bold></td><td>The obese fetal transcriptome</td></tr><tr><td>GSE73685</td><td>GPL6244</td><td>23</td><td/><td><bold>+</bold></td><td/><td/><td>Unique inflammatory transcriptome profiles at the maternal fetal interface and onset of human preterm and term birth</td></tr><tr><td>GSE83393</td><td>GPL17077</td><td>146</td><td><bold>+</bold></td><td/><td/><td/><td>Newborn sex-specific transcriptome signatures and gestational exposure to fine particles: findings from the ENVIRONAGE Birth Cohort</td></tr><tr><td valign="bottom"/><td valign="bottom">N</td><td valign="bottom">605</td><td valign="bottom">386</td><td valign="bottom">386</td><td valign="bottom">235</td><td valign="bottom">164</td><td valign="bottom"/></tr></tbody></table></table-wrap><p>To validate the findings of the meta-analysis, we assessed three independent cohorts to confirm which genes are associated with asthma risk (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Further details regarding validation and outcomes are discussed in the Results section. In brief, the goal of validation was to assess gene expression in an independent cohort (UIH Cohort [<xref ref-type="bibr" rid="bib24">Koenig et al., 2020</xref>]) where all subjects had complete metadata regarding newborn sex, gestational age, birthweight, and PP BMI. We sought to further understand whether transcriptomic differences in CBMCs corresponded to differences at the protein level (all three cohorts) or cell population level (<xref ref-type="bibr" rid="bib39">Olin et al., 2018</xref>). Finally, we assessed two identified proteins in another independent cohort (Project Viva Cohort [<xref ref-type="bibr" rid="bib38">Oken et al., 2015</xref>]) to test for association with pediatric asthma and pulmonary function outcomes at two follow-up time points.</p></sec><sec id="s2-2"><title>Meta-analysis of CBMC transcription associated with individual perinatal risk factors</title><p>Univariate random-effects models were generated to assess transcriptional changes in CBMCs with regards to newborn sex, gestational age, birthweight, and maternal PP BMI (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Differential expression (false discovery rate [FDR] &lt; 1%) was observed in 122, 34, 4, and 12 genes when comparing fetal sex, gestational age, birthweight, and maternal pre-pregnancy BMI, respectively (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>–<xref ref-type="supplementary-material" rid="supp4">4</xref>). When evaluating sex and gestational age, several expected genes were identified to have large transcriptional changes. With regards to sex-associated transcriptional changes, although there was no X or Y chromosome-wide gene enrichment, several genes located on X (<italic>KDM5C</italic>, <italic>SMC1A</italic>, <italic>TXLNG</italic>, and <italic>KDM6A</italic>) and Y (<italic>KDM5D</italic> and <italic>EIF1AY</italic>) chromosomes exhibited the largest effect sizes and most significant differences. In addition to expected sex-associated transcriptional changes, <italic>HBE1</italic>, a hemoglobin subunit associated with fetal erythropoiesis, was significantly associated with preterm gestational ages. To further validate our gestational age findings, we compared our univariate analysis with previously published results of differentially methylated regions associated with gestational age at birth estimated by last menstrual period (<xref ref-type="bibr" rid="bib3">Bohlin et al., 2016</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). A significant association was observed between differentially methylated genes and the effect size in our gestational age analysis, such that genes whose methylation increased with gestational age as reported by <xref ref-type="bibr" rid="bib3">Bohlin et al., 2016</xref> showed on average decreased expression with gestational age in our meta-analysis.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Pooled meta-analysis z-scores identify gene expression signatures related to asthma risk.</title><p>Significant (FDR &lt; 1%) genes and gene sets are colored by their association with either higher (red) or lower (blue) risk. (<bold>A</bold>) Volcano plots of gene expression for univariate analyses. Top 10 most significant genes labeled. (<bold>B</bold>) Word clouds of GO terms significantly enriched (FDR &lt; 1%) using the pooled z-score as pre-ranked list for GSEA. (<bold>C</bold>) Protein coding transcripts per million reads (pTPM) in peripheral blood cells (Human Protein Atlas and Monaco et al (<xref ref-type="bibr" rid="bib65">Uhlen et al., 2010</xref>; <xref ref-type="bibr" rid="bib36">Monaco et al., 2019</xref>) relative to pooled z-score. Each line represents one cell type; neutrophils highlighted in orange. (<bold>D</bold>) Spearman’s correlation between pooled z-statistic and individual analyses (diamonds). Average Spearman’s correlations between individual analyses and combination of all other analyses (circle), SD indicated by error bars.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63745-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Association between differentially methylated genes and gene expression changes with gestational age.</title><p>Comparison of effect size associated with gestational age for genes that were reported as differentially methylated by <xref ref-type="bibr" rid="bib3">Bohlin et al., 2016</xref>. Gene with increased methylation associated with gestational age demonstrate reduced expression with increasing gestational age.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63745-fig2-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Pooled meta-analysis gene expression signature</title><p>To identify the biological processes that are enriched by genes with transcriptional changes associated with higher or lower risk of asthma, the z-scores from each univariate meta-analysis were averaged, such that negative z-statistics were associated with lower risk (female, older gestational ages, higher birthweights, and lower maternal PP BMI) and positive z-statistics were associated with increased risk. Thus, the pooled z-score indicates the average probability that a gene’s expression is associated with either increased or decreased risk of asthma based on an individual’s demographics and birth characteristics. The averaged z-statistic was used as a pre-ranked list for gene set enrichment analysis. GO terms were assessed for enrichment; 18 and 19 GO terms were significantly enriched (FDR &lt; 1%) with regards to low- and high-risk profiles, respectively (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Genes associated with lower risk exhibited increased representation in GO terms involving innate immune signaling and defense, whereas high-risk genes were enriched in pathways involving translation and RNA metabolic processes.</p><p>Gene expression studies from pooled cellular populations (e.g. CBMCs, peripheral blood mononuclear cells, and tissues) can be influenced by the cellular composition. To determine whether specific cell population enrichment was associated with the pooled z-score, the Human Protein Atlas (HPA; <xref ref-type="bibr" rid="bib65">Uhlen et al., 2010</xref>, <xref ref-type="bibr" rid="bib36">Monaco et al., 2019</xref>) was utilized to assess the abundance of transcripts in peripheral blood leukocyte RNA transcriptomes in relationship to the pooled z-score. We observed a generalized increase in expression of low-risk genes in myeloid cells and high-risk genes in lymphoid cells. This pattern of expression was most pronounced in neutrophils (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). These results suggest that lower risk individuals have increased populations of myeloid cells in their CBMCs.</p><p>A potential confounder in pooling results is the potential over-representation of any one analysis. To assess bias in the pooled z-score, two analyses were performed (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). In the first assessment, z-scores from each individual analysis correlated with the pooled z-score. The highest correlations with the pooled z-score were the z-scores from the meta-analyses assessing gestational age at birth, newborn sex, and birthweight. Individual dataset z-scores for each dataset demonstrated a similar trend. In the second assessment, z-scores from each individual analysis were correlated with the combination of all other z-scores. Again, the pooled z-score had the highest average correlation followed by the meta-analyses. Together, this demonstrates that the pooled z-score does, indeed, amalgamate information across all of the analyses, with the most influence arising from gestational age at birth, newborn sex, and birthweight.</p></sec><sec id="s2-4"><title>Specific granule gene expression association with multiple pediatric asthma risk factors</title><p>To confirm gene expression changes associated with asthma risk stratification, pooled z-scores from the meta-analysis were compared with the UIH cohort, a cohort of individuals in which newborn sex, maternal PP BMI, gestational age at birth, and birthweight were known (<xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). UIH cohort z-scores were calculated from mRNAseq of CBMCs, where gene expression was modeled as a function of number of risk factors (<xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). We developed a method to validate the congruence between the UIH cohort and the pooled meta-analysis, which we termed the replication score (RS). This RS is the product of the pooled z-score from the meta-analysis and the UIH z-score (see Materials and methods). We assessed the relationship between RS cutoff, p-values, and number of genes (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Genes with a RS greater than three were identified as being sufficiently congruent. Fifty-one genes, 0.4% of all genes, tested had a RS greater than 3 (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). These identified genes corresponded well with the results of pooled z-score for gestational age at birth, newborn sex and birthweight, but showed limited correlation to maternal PP BMI. They had median p-values of 0.02, 0.01, 0.11, and 0.58 in the gestational age at birth, newborn sex, birthweight, and maternal PP BMI meta-analyses, and median p-value of 0.02 in the UIH cohort.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Validation cohort identifies gene signature associated with pediatric asthma risk factors.</title><p>Color labeling indicating association with either higher (red) or lower (blue) risk of pediatric asthma development. (<bold>A</bold>) Dot-plot demonstrating validation between meta-analysis pooled z-score and UIH cohort mRNAseq z-score. Colored and labeled dots indicate those with non-parametric replication score greater than 3 and 4, respectively. (<bold>B,C</bold>) Association between number of risk factors or individual risk factors and eigenvalue of gene signature (validation score &gt; 3), UIH cohort.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63745-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Replication score enriches for genes associated with multiple risk factors.</title><p>Splines (colored according to analysis) of median p-values (left y-axis) for genes with replication scores greater than corresponding cut-off (x-axis). Percentage of genes with replication score greater than corresponding cut-off. Vertical dashed lines two cutoffs: RS &gt; 0 and RS &gt; 3.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63745-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Protein–protein Interaction network of candidate genes.</title><p>(<bold>A</bold>) Protein–protein interaction network of candidate genes inferred from STRING (<xref ref-type="bibr" rid="bib58">Szklarczyk et al., 2019</xref>). Nodes are labeled by risk association: low (blue) and high (red) risk candidate genes. Nodes are colored (purple) if they are associated with GO cellular component term enrichment. (<bold>B</bold>) Word clouds of GO terms significantly enriched in candidate genes.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63745-fig3-figsupp2-v2.tif"/></fig></fig-group><p>Replicating genes were enriched for processes involved in vesicle biology (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Specifically, replicating genes associated with low risk were enriched for genes that are components of granulocyte specific granules (<italic>MS4A3</italic>, <italic>CEACAM8</italic>, <italic>OLR1</italic>, <italic>CAMP</italic>, <italic>LTF</italic>, <italic>CHI3L1</italic>, <italic>SLPI</italic>, <italic>PGLYRP1</italic>). With regards to genes associated with higher risk, genes involved in vesicle sorting/production (<italic>VPS28, VTI1B, FIS1</italic>) as well as several genes involved in vesicle membrane biology (<italic>AGPAT3</italic>, <italic>ELOVL6</italic>, <italic>TM7SF2</italic>) were identified.</p><p>To test whether replicating genes were associated with the number of risk factors, these 51 genes were assessed using principal component analysis. Using the first Eigenvector (explaining 41.3% of variance in replicating genes), a significant association (R [95% confidence interval (CI)=−0.51 [–0.73, –0.18], p-value&lt;0.01) was observed between UIH cohort Eigenvalues and number of epidemiologic risk factors (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Positive eigenvalues represent increased expression of low-risk genes and negative eigenvalues represent increased expression of high-risk genes. Although the associations with individual risk factors were in the expected directions, they were not significant (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), suggesting that the additive effect is greater than the individual.</p></sec><sec id="s2-5"><title>Cellular and protein abundance in relation to pediatric asthma risk factors</title><p>To further determine whether these changes are due to differences in cellular populations, we analyzed mass cytometry data published by Olin et al. for abundance of 21 different cell types in relationship to number of epidemiologic risk factors for pediatric asthma (<xref ref-type="bibr" rid="bib66">Votavova et al., 2011</xref>). Cord blood neutrophil abundance was inversely associated (R [95% CI]=−0.57 [–0.73, –0.34], Bonferroni p-adj&lt;0.001) with the number of risk factors (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Other myeloid cell types, CD14+ monocytes, and myeloid-derived dendritic cells also had negative correlations but were weaker and not significant after multiple testing correction (<bold>data not shown</bold>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Cellular and proteomic differences associated with pediatric asthma risk factors.</title><p>(<bold>A–C</bold>) Re-analysis of publicly available data from <xref ref-type="bibr" rid="bib39">Olin et al., 2018</xref>. (<bold>A</bold>) Percentage of neutrophils in cord blood (transformed using centered log-ratios, CLR) correlated with number of risk factors. Pearson’s correlation (R) and Bonferroni adjusted p-value reported. (<bold>B</bold>) Pearson’s correlation coefficients (R) for plasma-protein concentration and number of risk factors distributed based on risk association of proteins as per <xref ref-type="fig" rid="fig3">Figure 3</xref>. Corresponding mRNA from CBMCs were identified for low-risk associated proteins (blue) and no risk associated proteins (dark gray). Most significant negative protein correlations with neutrophil-enriched mRNA (Human Protein Atlas [<xref ref-type="bibr" rid="bib65">Uhlen et al., 2010</xref>]) are notated. Proteins identified in previous analysis without corresponding mRNA shown light gray. (<bold>C</bold>) Heatmap of Pearson’s correlations between neutrophils and neutrophil-derived proteins identified in (<bold>B</bold>). (<bold>D</bold>) Association between PGLYRP-1 umbilical cord serum concentration, PGLYRP-1 CBMC mRNA, and number of risk factors in UIH cohort.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63745-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Association between PGLYRP-1 and sIL6Rα in UIH and Project Viva cohorts.</title><p>Scatter plot displaying association between PGLYRP-1 and sIL6Rα in UIH (blue) and Project Viva (yellow) cohorts. Univariate regression lines are shown for both cohorts. Distributions for PGLYRP-1 and sIL6Rα are shown in the margins for each cohort.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63745-fig4-figsupp1-v2.tif"/></fig></fig-group><p>Extending these findings from gene expression to protein abundance, reported umbilical cord plasma-protein abundance data was correlated with number of risk factors in a secondary analysis (<xref ref-type="bibr" rid="bib39">Olin et al., 2018</xref>). Serum proteins from genes that replicated with low risk had on average negative correlations with number of risk factors (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). No proteins from the high-risk genes were tested in plasma, due to their intracellular localization. Notably, proteins (CEACAM8, PGLYRP-1, CHIT1, sIL6Rα, MMP-9, and OSM) predicted to be enriched in neutrophils by the HPA (<xref ref-type="bibr" rid="bib65">Uhlen et al., 2010</xref>) had strong correlations with both neutrophil abundance and number of risk factors (<xref ref-type="fig" rid="fig4">Figure 4B,C</xref>).</p><p>We hypothesized that the serum concentration of proteins identified as low risk in our transcriptomic analysis would correlate with mRNA abundance in CBMCs, whereas those not associated with risk would not correlate with mRNA in CBMCs. To test this hypothesis, we used the UIH cohort to correlate mRNA abundance with serum protein concentration of PGLYRP-1 (low risk) and sIL6Rα (no risk). We observed a significant (R [95% CI]=0.39 [0.03, 0.66], p&lt;0.05) association between PGLYRP-1 protein concentration and mRNA (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Consistent with transcriptomic results, PGLYRP-1 cord blood serum concentration was inversely associated with number of risk factors (R [95% CI]=−0.51 [–0.74, –0.17], p&lt;0.01). sIL6Rα was neither associated with its mRNA in CBMCs (R [95% CI]=0.37 [–0.22, 0.77], p=0.21) nor associated with the number of risk factors (R [95% CI]=0.20 [–0.39, 0.67], p=0.50).</p></sec><sec id="s2-6"><title>Demographic associations with serum neutrophil proteins in UIH and Project Viva cohorts</title><p>We tested the association between PGLYRP-1 and sIL6Rα, individual risk factors, and demographics in the UIH and Project Viva cohorts. Cord blood serum was available in a subset of individuals (n = 358) from Project Viva (<xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>). There was no significant difference (p&gt;0.05, Wilcoxon rank sum test) in PGLYRP-1 or sIL6Rα between UIH and Project Viva cohorts (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Consistent with our previous observations, PGLYRP-1 and sIL6Rα were positively correlated in both UIH (R [95% CI]=0.21 [−0.16, 0.54]) and Project Viva (R [95% CI]=0.19 [0.09, 0.29]) cohorts. Similar to the observation in the UIH cohort, there was a negative association between PGLYRP-1 and number of risk factors in Project Viva (β [95% CI]=−0.22 [−0.36, –0.07], p-value=0.003) (<xref ref-type="table" rid="table2">Table 2</xref>). This association was driven by the relationship between PGLYRP-1, gestational age, and sex. There was no association with PP BMI or birthweight when taking into account gestational age and sex. Furthermore, there was no association of sIL6Rα with the number or risk factors or any individual risk factor. Interestingly, there was an inverse relationship observed in both the UIH and Project Viva cohorts between sIL6Rα and self-reported maternal race as Black/African-American. Collectively, these results suggest that increased abundance of mRNA from genes localizing to neutrophil-specific granules are associated with the number of risk factors for pediatric asthma. These changes in mRNA are reflected in the abundance of these specific granule proteins in serum and plasma.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Univariate associations between demographics and serum proteins.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom"/><th colspan="2" valign="bottom">UIH (n = 29)</th><th colspan="2" valign="bottom">Project viva (n = 358)</th></tr><tr><th valign="bottom"/><th valign="bottom">β (95% CI)</th><th valign="bottom">p-value</th><th valign="bottom">β (95% CI)</th><th valign="bottom">p-value</th></tr></thead><tbody><tr><td valign="bottom">PGLYRP-1 Z-score*</td><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="bottom">Number of risk factors<sup>†</sup></td><td valign="bottom">−0.54 (–0.88, –0.19)</td><td valign="bottom">0.005</td><td valign="bottom">−0.22 (–0.36, –0.07)</td><td valign="bottom">0.003</td></tr><tr><td valign="bottom">Maternal race: White (ref)</td><td valign="bottom">0 (ref)</td><td valign="bottom"/><td valign="bottom">0 (ref)</td><td valign="bottom"/></tr><tr><td valign="bottom">Maternal race: Black</td><td valign="bottom">0.01 (–0.83, 0.86)</td><td valign="bottom">0.97</td><td valign="bottom">0.15 (–0.16, 0.46)</td><td valign="bottom">0.34</td></tr><tr><td valign="bottom">Maternal race: Hispanic</td><td valign="bottom">1.03 (0.05, 2.01)</td><td valign="bottom">0.04</td><td valign="bottom">0.40 (–0.07, 0.86)</td><td valign="bottom">0.10</td></tr><tr><td valign="bottom">Maternal race: Other</td><td valign="bottom">1.54 (–0.46, 3.54)</td><td valign="bottom">0.12</td><td valign="bottom">0.10 (–0.25, 0.46)</td><td valign="bottom">0.57</td></tr><tr><td valign="bottom">Maternal atopy</td><td valign="bottom">−0.14 (–0.92, 0.64)</td><td valign="bottom">0.72</td><td valign="bottom">0.06 (–0.16, 0.28)</td><td valign="bottom">0.58</td></tr><tr><td valign="bottom">Maternal pre-pregnancy BMI</td><td valign="bottom">−0.03 (–0.09, 0.02)</td><td valign="bottom">0.25</td><td valign="bottom">0.01 (–0.01, 0.03)</td><td valign="bottom">0.56</td></tr><tr><td valign="bottom">Maternal smoking: never (ref)</td><td valign="bottom">0 (ref)</td><td valign="bottom"/><td valign="bottom">0 (ref)</td><td valign="bottom"/></tr><tr><td valign="bottom">Maternal smoking: former</td><td valign="bottom">0.09 (–0.92, 1.12)</td><td valign="bottom">0.84</td><td valign="bottom">−0.16 (–0.44, 0.11)</td><td valign="bottom">0.25</td></tr><tr><td valign="bottom">Maternal smoking: during pregnancy</td><td valign="bottom">–</td><td valign="bottom">–</td><td valign="bottom">−0.12 (–0.47, 0.22)</td><td valign="bottom">0.48</td></tr><tr><td valign="bottom">Maternal college graduate</td><td valign="bottom">0.07 (–0.80, 0.93)</td><td valign="bottom">0.87</td><td valign="bottom">−0.12 (–0.34, 0.10)</td><td valign="bottom">0.27</td></tr><tr><td valign="bottom">Any antibiotic use during pregnancy</td><td valign="bottom">–</td><td valign="bottom">–</td><td valign="bottom">0.20 (-0.02, 0.43)</td><td valign="bottom">0.08</td></tr><tr><td valign="bottom">Gestational age weeks</td><td valign="bottom">0.25 (–0.01, 0.51)</td><td valign="bottom">0.06</td><td valign="bottom">0.12 (0.06, 0.19)</td><td valign="bottom">0.0003</td></tr><tr><td valign="bottom">Birthweight adj GA and Sex (Z-score)</td><td valign="bottom">0.33 (–1.07, 1.74)</td><td valign="bottom">0.63</td><td valign="bottom">0.03 (–0.09, 0.14)</td><td valign="bottom">0.66</td></tr><tr><td valign="bottom">Female</td><td valign="bottom">0.39 (–0.37, 1.15)</td><td valign="bottom">0.30</td><td valign="bottom">0.31 (0.11, 0.52)</td><td valign="bottom">0.003</td></tr><tr><td valign="bottom">C-section</td><td valign="bottom">−0.08 (–0.89, 0.74)</td><td valign="bottom">0.85</td><td valign="bottom">−0.29 (–0.55, –0.02)</td><td valign="bottom">0.03</td></tr><tr><td valign="bottom">Child’s race: White (ref)</td><td valign="bottom">–</td><td valign="bottom">–</td><td valign="bottom">0 (ref)</td><td valign="bottom"/></tr><tr><td valign="bottom">Child’s race: Black</td><td valign="bottom">–</td><td valign="bottom">–</td><td valign="bottom">0.16 (–0.14, 0.46)</td><td valign="bottom">0.31</td></tr><tr><td valign="bottom">Child’s race: Hispanic</td><td valign="bottom">–</td><td valign="bottom">–</td><td valign="bottom">0.18 (–0.31, 0.68)</td><td valign="bottom">0.46</td></tr><tr><td valign="bottom">Child’s race: Other</td><td valign="bottom">–</td><td valign="bottom">–</td><td valign="bottom">0.06 (-0.27, 0.38)</td><td valign="bottom">0.73</td></tr><tr><td valign="bottom">sIL6Rα Z-score*</td><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/><td valign="bottom"/></tr><tr><td valign="bottom">Number of risk factors<sup>†</sup></td><td valign="bottom">−0.14 (–0.54, –0.25)</td><td valign="bottom">0.48</td><td valign="bottom">0.02 (–0.13, 0.16)</td><td valign="bottom">0.81</td></tr><tr><td valign="bottom">Maternal race: White (ref)</td><td valign="bottom">0 (ref)</td><td valign="bottom"/><td valign="bottom">0 (ref)</td><td valign="bottom"/></tr><tr><td valign="bottom">Maternal race: Black</td><td valign="bottom">−1.04 (–1.90, –0.19)</td><td valign="bottom">0.02</td><td valign="bottom">−0.29 (–0.60, 0.02)</td><td valign="bottom">0.07</td></tr><tr><td valign="bottom">Maternal race: Hispanic</td><td valign="bottom">−0.36 (–1.34, 0.62)</td><td valign="bottom">0.45</td><td valign="bottom">0.34 (-0.12, 0.80)</td><td valign="bottom">0.15</td></tr><tr><td valign="bottom">Maternal race: Other</td><td valign="bottom">0.4 (–1.61, 2.42)</td><td valign="bottom">0.68</td><td valign="bottom">−0.03 (–0.39, 0.32)</td><td valign="bottom">0.85</td></tr><tr><td valign="bottom">Maternal atopy</td><td valign="bottom">−0.23 (–1.01, 0.54)</td><td valign="bottom">0.55</td><td valign="bottom">−0.08 (–0.30, 0.14)</td><td valign="bottom">0.47</td></tr><tr><td valign="bottom">Maternal pre-pregnancy BMI</td><td valign="bottom">−0.04 (–0.10, 0.01)</td><td valign="bottom">0.12</td><td valign="bottom">0.00 (–0.02, 0.02)</td><td valign="bottom">0.72</td></tr><tr><td valign="bottom">Maternal smoking: never (ref)</td><td valign="bottom">0 (ref)</td><td valign="bottom"/><td valign="bottom">0 (ref)</td><td valign="bottom"/></tr><tr><td valign="bottom">Maternal smoking: former</td><td valign="bottom">−0.90 (–1.86, 0.06)</td><td valign="bottom">0.07</td><td valign="bottom">−0.23 (–0.50, 0.05)</td><td valign="bottom">0.10</td></tr><tr><td valign="bottom">Maternal smoking: during pregnancy</td><td valign="bottom">–</td><td valign="bottom">–</td><td valign="bottom">−0.12 (–0.46, 0.22)</td><td valign="bottom">0.48</td></tr><tr><td valign="bottom">Maternal college graduate</td><td valign="bottom">0.44 (–0.41, 1.29)</td><td valign="bottom">0.29</td><td valign="bottom">−0.02 (–0.24, 0.19)</td><td valign="bottom">0.84</td></tr><tr><td valign="bottom">Any antibiotic use during pregnancy</td><td valign="bottom">–</td><td valign="bottom">–</td><td valign="bottom">0.04 (–0.19, 0.26)</td><td valign="bottom">0.76</td></tr><tr><td valign="bottom">Gestational age weeks</td><td valign="bottom">−0.11 (–0.39, 0.17)</td><td valign="bottom">0.43</td><td valign="bottom">−0.04 (–0.10, 0.03)</td><td valign="bottom">0.29</td></tr><tr><td valign="bottom">Birthweight adj GA and sex (Z-score)</td><td valign="bottom">−0.15 (–1.57, 1.26)</td><td valign="bottom">0.82</td><td valign="bottom">−0.07 (–0.18, 0.04)</td><td valign="bottom">0.23</td></tr><tr><td valign="bottom">Female</td><td valign="bottom">0.48 (–0.28, 1.23)</td><td valign="bottom">0.21</td><td valign="bottom">0.05 (–0.16, 0.26)</td><td valign="bottom">0.63</td></tr><tr><td valign="bottom">C-section</td><td valign="bottom">−0.60 (–1.38, 0.18)</td><td valign="bottom">0.12</td><td valign="bottom">−0.14 (–0.41, 0.12)</td><td valign="bottom">0.29</td></tr><tr><td valign="bottom">Child’s race: White (ref)</td><td valign="bottom">–</td><td valign="bottom">–</td><td valign="bottom">0 (ref)</td><td valign="bottom"/></tr><tr><td valign="bottom">Child’s race: Black</td><td valign="bottom">–</td><td valign="bottom">–</td><td valign="bottom">−0.24 (–0.54, 0.05)</td><td valign="bottom">0.11</td></tr><tr><td valign="bottom">Child’s race: Hispanic</td><td valign="bottom">–</td><td valign="bottom">–</td><td valign="bottom">0.27 (–0.22, 0.76)</td><td valign="bottom">0.28</td></tr><tr><td valign="bottom">Child’s race: Other</td><td valign="bottom">–</td><td valign="bottom">–</td><td valign="bottom">0.02 (–0.30, 0.34)</td><td valign="bottom">0.90</td></tr></tbody></table><table-wrap-foot><fn><p>*Serum protein concentrations for UIH and Project Viva were log10 transformed and converted into an internal Z-score.</p><p><sup>†</sup>Number of risk factors determined by preterm birth, maternal BMI &gt; 29.9, male, birthweight (z-score) &lt; −1.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-7"><title>Serum neutrophil protein association with pediatric pulmonary outcomes</title><p>In context of our previous results, we hypothesized that specific granule protein abundance in serum is associated with risk of pediatric asthma and this process is independent of neutrophil abundance. To evaluate this hypothesis, we measured PGLYRP-1 (present in neutrophil-specific granule and correlates with its mRNA in CBMCs) and sIL6Rα (derived from neutrophils but not present in specific granules and does not correlate with its mRNA in CBMCs) in umbilical cord blood serum. At two follow-up time points, asthma outcomes and expiratory flow volumes were modeled as a function of PGLYRP-1 and sIL6Rα in a subset of individuals in Project Viva (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). The demographics of the subset of individuals from Project Viva from which umbilical cord serum was available had a similar demographic profile as the full cohort. One notable difference was a sizeable decreased response rate for asthma outcomes at the early-teenage follow-up compared to the full cohort (32% subset vs. 47% full cohort).</p><p>PGLYRP-1 and sIL6Rα were modeled as predictors for current asthma at mid-childhood (median age ~7.7 years old) and early-teen (median age ~12.3 years old) follow ups (<xref ref-type="table" rid="table3">Table 3</xref>). Four regression models were used to estimate the association between asthma outcomes: univariate, adjustment for child’s birth characteristics and demographics, adjustment for mother’s demographics, and adjustment for birth characteristics and all demographics (reported in manuscript). The abundance of PGLYRP-1 was significantly associated with current asthma at mid-childhood (adjusted odds ratio [OR] [95% CI]: 0.50 [0.31, 0.77] per 1 SD increase, p-value=0.003) (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). There were no significant associations between current asthma and PGLYRP-1 at the early-teen follow up; however, the CI at this time point was much wider, likely secondary to the smaller sample size. There were no significant associations between sIL6Rα with any asthma outcome at either time point.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Increased umbilical cord blood serum PGLYRP-1 is associated with increased FEV<sub>1</sub>/FVC and reduced odds of pediatric asthma.</title><p>Samples and data derived from a subset of Project Viva (n=358). Odds ratio and coefficient estimates are based on 1 SD increase in serum proteins (PGLYRP-1, sIL6Rα). Error bars indicate 95% CI. Adjusted model co-variates: gestational age, birthweight adjusted for gestational age and sex, mode of delivery, child’s sex, child's race/ethnicity, maternal pre-pregnancy BMI, maternal level of education, maternal atopy, antibiotic exposure during pregnancy, and early-life smoke exposure. (<bold>A</bold>) PGLYRP-1 and sIL6Rα concentrations in umbilical cord blood serum association with current asthma at mid-childhood and early-teenage time points (determined by questionnaire responses). (<bold>B</bold>) PGLYRP-1 and sIL6Rα concentrations in umbilical cord blood serum association with FEV<sub>1</sub>/FVCx100 at mid-childhood and early-teenage follow ups. <bold>***</bold>p&lt;0.001, <bold>**</bold>p&lt;0.01, <bold>*</bold>p&lt;0.05, <bold>#</bold>p&lt;0.1.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63745-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Cord blood serum proteins in relationship to outcomes.</title><p>(<bold>A</bold>) PGLYRP-1 concentration in umbilical cord blood serum in relationship to current asthma determined by questionnaire response and (<bold>B</bold>) FEV<sub>1</sub>/FVCx100 at mid-childhood and early-teenage follow ups. (<bold>C</bold>) sIL6Rα concentration in umbilical cord blood serum in relationship to current asthma determined by questionnaire response and (<bold>D</bold>) FEV<sub>1</sub>/FVCx100 at mid-childhood and early-teenage follow ups.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63745-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Relative importance of predictors for pediatric asthma and FEV<sub>1</sub>/FVC.</title><p>Relative importance, displayed as percent of variance explained, for variables used in regressions (<xref ref-type="table" rid="table3">Table 3</xref>, model 3) for current asthma at mid-childhood and FEV<sub>1</sub>/FVC in early-teen years. Variance estimated for logistic regression as Mcfadden’s pseudo-R (<xref ref-type="bibr" rid="bib19">Jaakkola et al., 2006</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63745-fig5-figsupp2-v2.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>Subset analysis for all covariates used in regression models.</title><p>Funnel plot demonstrating relationship effect size estimates and measurement error for subset analyses for (<bold>A</bold>) current mid-childhood asthma and (<bold>B</bold>) FEV<sub>1</sub>/FVCx100 in early-teen years. 95% CI (botted lines) and 99% CI (dashed lines) displayed.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63745-fig5-figsupp3-v2.tif"/></fig></fig-group><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>Association between serum protein concentration and asthma outcomes.</title></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th colspan="2">Mid-childhood</th><th colspan="2">Early-teen</th></tr></thead><tbody><tr><td/><td/><td>Current asthma, OR (95% CI)</td><td>Ever asthma, OR (95% CI)</td><td>Current asthma, OR (95% CI)</td><td>Ever asthma, OR (95% CI)</td></tr><tr><td>PGLYRP-1 Z-score*</td><td/><td/><td/><td/><td/></tr><tr><td/><td>Univariate</td><td>0.52 (0.35, 0.75)</td><td>0.52 (0.36, 0.74)</td><td>0.65 (0.39, 1.10)</td><td>0.64 (0.45, 0.89)</td></tr><tr><td/><td>Model 1<sup>†</sup></td><td>0.57 (0.37, 0.85)</td><td>0.54 (0.36, 0.79)</td><td>0.86 (0.48, 1.54)</td><td>0.72 (0.50, 1.03)</td></tr><tr><td/><td>Model 2<sup>‡</sup></td><td>0.57 (0.26, 0.65)</td><td>0.41 (0.26, 0.61)</td><td>0.62 (0.35, 1.09)</td><td>0.61 (0.42, 0.87)</td></tr><tr><td/><td>Model 3<sup>#</sup></td><td>0.50 (0.31, 0.77)</td><td>0.48 (0.31, 0.77)</td><td>0.88 (0.45, 1.72)</td><td>0.74 (0.51, 1.07)</td></tr><tr><td>sIL6Rα Z-score*</td><td/><td/><td/><td/><td/></tr><tr><td/><td>Univariate</td><td>0.87 (0.61, 1.23)</td><td>0.93 (0.67, 1.29)</td><td>0.75 (0.42, 1.28)</td><td>0.93 (0.66, 1.29)</td></tr><tr><td/><td>Model 1<sup>†</sup></td><td>0.83 (0.56, 1.23)</td><td>0.89 (0.63, 1.30)</td><td>0.68 (0.37, 1.21)</td><td>0.90 (0.63, 1.27)</td></tr><tr><td/><td>Model 2<sup>‡</sup></td><td>0.83 (0.57, 1.24)</td><td>0.90 (0.63, 1.28)</td><td>0.67 (0.33, 1.27)</td><td>0.93 (0.65, 1.31)</td></tr><tr><td/><td>Model 3<sup>#</sup></td><td>0.83 (0.55, 1.25)</td><td>0.90 (0.62, 1.30)</td><td>0.60 (0.27, 1.19)</td><td>0.88 (0.61, 1.27)</td></tr></tbody></table><table-wrap-foot><fn><p>*Serum protein concentrations were log10 transformed and converted into an internal Z-score.</p><p><sup>†</sup>Serum protein concentrations were log10 transformed and conver gestational age, birthweight adjusted for gestational age, mode of delivery, child’s sex, child’s race/ethnicity.</p></fn><fn><p><sup>‡</sup>(Mother’s demographics): adjusted for maternal pre-pregnancy BMI, maternal race/ethnicity, maternal level of education, maternal atopy, antibiotic exposure during pregnancy, smoking during pregnancy, 6 months or 1 year.</p><p><sup>#</sup>Model 3 (all demographics and birth characteristics): adjusted for all demographics and characteristics in models 1 and 2 except maternal race/ethnicity. This reported value in manuscript.</p></fn></table-wrap-foot></table-wrap><p>We also performed analyses to estimate the relationship of cord blood PGLYRP-1 and sIL6Rα with FEV<sub>1</sub>/FVCx100 ratio and bronchodilator response (BDR) at mid-childhood and early-teen follow-up time points (<xref ref-type="table" rid="table4">Table 4</xref>). There was no significant association between sIL6Rα and FEV<sub>1</sub>/FVCx100 ratio at either time point. PGLYRP-1 and sIL6Rα were not associated with BDR at either time point. However, there was trend toward an association between PGLYRP-1 concentration and FEV<sub>1</sub>/FVCx100 ratio at mid-childhood (adjusted β [95% CI]: 1.18 [–0.18, 2.56] per 1 SD increase, p-value=0.09) and significant association at the early-teen follow up (adjusted β [95% CI]: 1.15 [0.20, 2.10] per 1 SD increase, p-value=0.02) (<xref ref-type="fig" rid="fig5">Figure 5B</xref>).</p><table-wrap id="table4" position="float"><label>Table 4.</label><caption><title>Association between serum protein concentration and pulmonary function.</title></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th colspan="2">Mid-childhood</th><th colspan="2">Early-teen</th></tr><tr><th/><th/><th>FEV<sub>1</sub>/FVCx100 β (95% CI)</th><th>BDR β (95% CI)</th><th>FEV<sub>1</sub>/FVCx100 β (95% CI)</th><th>BDR β (95% CI)</th></tr></thead><tbody><tr><td>PGLYRP-1 Z-score*</td><td/><td/><td/><td/><td/></tr><tr><td/><td>Univariate</td><td>1.38 (0.15, 2.61)</td><td>0.10 (−1.83, 2.03)</td><td>1.45 (0.49, 2.42)</td><td>−0.68 (−1.54, 0.17)</td></tr><tr><td/><td>Model 1<sup>†</sup></td><td>1.12 (−0.18, 2.41)</td><td>0.53 (−1.44, 2.51)</td><td>1.05 (0.11, 1.98)</td><td>−0.49 (−1.40, 0.41)</td></tr><tr><td/><td>Model 2<sup>‡</sup></td><td>1.38 (0.08, 2.69)</td><td>0.61 (−1.40, 2.63)</td><td>1.53 (0.54, 2.53)</td><td>−0.58 (−1.49, 0.34)</td></tr><tr><td/><td>Model 3<sup>#</sup></td><td>1.19 (−0.19, 2.56)</td><td>1.00 (−1.04, 3.04)</td><td>1.15 (0.20, 2.10)</td><td>−0.35 (−1.29, 0.59)</td></tr><tr><td>sIL6Rα Z-score*</td><td/><td/><td/><td/><td/></tr><tr><td/><td>Univariate</td><td>0.95 (−0.31, 2.20)</td><td>−0.38 (−2.45, 1.69)</td><td>0.11 (−0.86, 1.09)</td><td>0.65 (−0.24, 1.54)</td></tr><tr><td/><td>Model 1<sup>†</sup></td><td>0.96 (−0.30, 2.21)</td><td>−0.37 (-2.41, 1.67)</td><td>0.02 (−0.87, 0.92)</td><td>0.71 (−0.19, 1.61)</td></tr><tr><td/><td>Model 2<sup>‡</sup></td><td>0.88 (−0.40, 2.16)</td><td>−0.62 (−2.62, 1.39)</td><td>−0.02 (−1.00, 0.97)</td><td>0.75 (−0.17, 1.66)</td></tr><tr><td/><td>Model 3<sup>#</sup></td><td>0.92 (−0.36, 2.20)</td><td>−0.11 (−0.96, 0.70)</td><td>−0.05 (−0.94, 0.85)</td><td>0.79 (−0.12, 1.69)</td></tr></tbody></table><table-wrap-foot><fn><p>*Serum protein concentrations were log10 transformed and converted into an internal Z-score.</p><p><sup>†</sup>Serum protein concentrations were log10 transformed and converted into an internal Z-scoreupplemental Data\\Table 4_Association pulmonary outcomes.xlsx’ &quot;Shed's race/ethnicity.</p></fn><fn><p><sup>‡</sup>(Mother's demographics): adjusted for maternal pre-pregnancy BMI, maternal race/ethnicity, maternal level of education, maternal atopy, antibiotic exposure during pregnancy, smoking during pregnancy, 6 months or 1 year.</p><p><sup>#</sup>Model 3 (all demographics and birth characteristics): adjusted for all demographics and characteristics in models 1 and 2 except maternal race/ethnicity. This the reported value in manuscript.</p></fn></table-wrap-foot></table-wrap><p>To further our understanding of the relationship between PGLYRP-1 and outcomes, we performed two secondary analyses of models adjusted for all demographics and birth characteristics. First, we assessed the total variance explained by the regression model adjusting for both birth characteristics and demographics, and the variance explained by each of the individual predictors in the model. Assessing current asthma risk at mid-childhood, the regression model explained approximately 18% of the variance, and PGLYRP-1 was the most important predictor. Assessing current FEV<sub>1</sub>/FVCx100 at early-teen time point, the model explained approximately 26% of variance, and PGLYRP-1 was the second most important predictor (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Second, to identify covariates that modify the effect of PGLYRP-1, we performed subset analyses (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>). Small for gestational age and children identified by their mothers as ‘Other’ race/ethnicity displayed significantly different associations between PGLYRP-1 and mid-childhood asthma. Small for gestational age and children with obese mothers displayed significantly different associations between PGLYRP-1 and FEV<sub>1</sub>/FVC.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our study has identified a novel association between epidemiologic risk, neutrophil-specific granules, and pediatric pulmonary outcomes. These findings implicate a role for PGLYRP-1 and other specific granule proteins as predictors of pediatric asthma risk and pulmonary function. This is in contrast to sIL6Rα, which is not localized to specific granules, its protein abundance is not regulated by transcription, and is not associated with any pulmonary outcomes.</p><p>By pooling the meta-analysis results, we established an association between multiple risk factors and the expression of genes involved in innate immunity and nucleic acid metabolism. We hypothesized that this gene signature represents increased myelopoiesis in utero and correlates with perinatal risk for pediatric asthma. During the process of myeloid cell differentiation, production of proteins responsible for defense against microbes and pro-inflammatory signaling (e.g., IL-1β) are amplified, while translational activity and nucleolar size wane (<xref ref-type="bibr" rid="bib74">Zhu et al., 2017</xref>; <xref ref-type="bibr" rid="bib16">Grassi et al., 2018</xref>). In our analysis, lower risk genes had higher expression in myeloid cells, most notably neutrophils. The low-risk genes were enriched for those that are implicated in defense responses towards bacteria and fungi. Additionally, this gene signature was strongly correlated with gestational age at birth, newborn sex, and birthweight (weaker association with maternal PP BMI). Our findings parallel previous literature, which has demonstrated that preterm birth, male sex, and low birthweight are associated with reduced abundance of neutrophils and monocytes (<xref ref-type="bibr" rid="bib15">Glasser et al., 2015</xref>).</p><p>Our replication of the pooled meta-analysis with the UIH cohort pointed toward genes located and involved in the biology of neutrophil-specific (secondary) granules. In particular, lower risk individuals had higher expression of genes whose protein products are luminal (<italic>PGLRYP1</italic>, <italic>LTF</italic>, <italic>PTX3</italic>, <italic>CHI3L1</italic>, <italic>CAMP</italic>, <italic>SLPI</italic>) and membrane (<italic>CEACAM8</italic>, <italic>MS4A3</italic>, <italic>OLR1</italic>) components of specific granules (<xref ref-type="bibr" rid="bib50">Rørvig et al., 2013</xref>). We demonstrate that the additive effect of multiple risk factors is associated with the reduction of transcription and protein products of specific granules in umbilical cord blood serum. Notably, our re-analysis of mass cytometry and proteomic data demonstrated a correlation between PGLYRP-1 in serum and neutrophil abundance (<xref ref-type="bibr" rid="bib39">Olin et al., 2018</xref>). Previous literature has shown that deficiency of secretory leukocyte protease inhibitor (SLPI) leads to impairment of neutrophil development and abundance (<xref ref-type="bibr" rid="bib23">Klimenkova et al., 2014</xref>). Furthermore, individuals with specific granule deficiency syndrome have abnormal neutrophil morphology, increased susceptibility to infections, and increased risk of acute myeloid leukemia (<xref ref-type="bibr" rid="bib26">Lekstrom-Himes et al., 1999</xref>). Thus, this further supports the notion that neutrophil differentiation and survival is partially dependent on secondary granule generation.</p><p>To further investigate how these findings are related to pediatric asthma, we chose to compare PGLYRP-1, sIL6Rα, and their associations with asthma and lung function outcomes. PGLYRP-1 and sIL6Rα were chosen because both were correlated with neutrophil abundance, yet they are derived from different processes. Variation in abundance of PGLYRP-1 in serum is due to changes in neutrophil degranulation and transcription of <italic>PGLYRP1</italic>, whereas sIL6Rα is derived from receptor shedding and differential splicing of its mRNAs (<xref ref-type="bibr" rid="bib20">Jones et al., 2001</xref>; <xref ref-type="bibr" rid="bib45">Read et al., 2015</xref>). Thus, if perinatal neutrophil abundance is associated with pediatric asthma, both PGLYRP-1 and sIL6Rα should demonstrate associations with these outcomes. In contrast, we observed a significant relationship between mid-childhood asthma and PGLYRP-1, not sIL6Rα. These data indicate that serum abundance of specific granule contents likely has a larger and more significant association with pediatric asthma risk compared to the abundance of cord blood neutrophils.</p><p>PGLYRP-1 concentration was associated with gestational age, sex, and mode of delivery. Gestational age at birth, sex, mode of delivery, and birthweight may influence not only the abundance of neutrophils, but also their functionality (e.g. phagocytosis, cytokine production, respiratory burst) (<xref ref-type="bibr" rid="bib25">Lawrence et al., 2017</xref>). In contrast, sIL6Rα was only associated with maternal self-reported race, specifically in those who were Black/African-American. Notably, individuals of African descent on average have baseline lower neutrophil counts without any functional consequences (<xref ref-type="bibr" rid="bib47">Reich et al., 2009</xref>). Together, this highlights that PGLYRP-1 is a potential serologic marker of neutrophil functional maturity whereas sIL6Rα likely represents the total neutrophil abundance at birth.</p><p>Whether PGLYRP-1 has a causal role in asthma pathogenesis or is merely a biomarker for risk remains to be determined. PGLYRP-1 has antimicrobial function, although the concentration we observed in cord blood is below those reported for in vitro studies (<xref ref-type="bibr" rid="bib22">Kashyap et al., 2011</xref>; <xref ref-type="bibr" rid="bib29">Liu et al., 2000</xref>; <xref ref-type="bibr" rid="bib68">Wang et al., 2007</xref>). PGLYRP-1 functions synergistically in vitro with other antimicrobials (e.g. lysozyme), so potential benefit as an antimicrobial cannot be ruled out considering that <italic>pglyrp-1<sup>−</sup></italic><sup>/−</sup> mice are more susceptible to infections (<xref ref-type="bibr" rid="bib29">Liu et al., 2000</xref>; <xref ref-type="bibr" rid="bib68">Wang et al., 2007</xref>; <xref ref-type="bibr" rid="bib8">Dziarski et al., 2003</xref>; <xref ref-type="bibr" rid="bib13">Ghosh et al., 2009</xref>; <xref ref-type="bibr" rid="bib18">Gupta et al., 2020</xref>; <xref ref-type="bibr" rid="bib40">Osanai et al., 2011</xref>). Interestingly, mammalian PGLYRP-1 does not hydrolyze peptidoglycan, and its orthologs appear divergent from ancestral PGLYRPs, which contain enzymatic activity; thus, it may have roles other than that of an antimicrobial (<xref ref-type="bibr" rid="bib9">Dziarski and Gupta, 2006</xref>). It is also possible that other individual specific granule proteins or their cumulative effects are associated with pediatric asthma. Further studies will be required to determine a mechanistic role for either PGLYRP-1 or other specific granule proteins.</p><p>Several murine studies link PGLYRP-1 to increased airway resistance and perturbed immunity in response to house dust mite (<xref ref-type="bibr" rid="bib41">Park et al., 2013</xref>; <xref ref-type="bibr" rid="bib73">Yao et al., 2013</xref>). Contextualization of the murine studies with our results is largely confounded by the fact these murine studies have utilized adult mice deficient in PGLYRP-1 via germ-line deletion. These studies have largely demonstrated that the genetic absence of <italic>pglyrp1</italic> leads to moderately reduced airway resistance, IgE, and T2 cytokine production in response to house dust mite exposure after sensitization. Notably, genetic absence of <italic>pglyrp1</italic> does not completely protect against airway inflammatory changes. Furthermore, one study has demonstrated that bone marrow reconstitution with WT bone marrow prior allergen sensitization abrogates this effect (<xref ref-type="bibr" rid="bib73">Yao et al., 2013</xref>), suggesting PGLYRP-1 presence in adult mice at the time of sensitization is responsible for increased airway resistance and perturbed immunity. These results are not entirely surprising as PGLYRP-1 is reported to be a pro-inflammatory TREM-1 ligand and thus may propagate inflammation (<xref ref-type="bibr" rid="bib45">Read et al., 2015</xref>). Extending this point, there are reported associations between increased serum PGLYRP-1 and systemic inflammatory conditions in adulthood (e.g. rheumatoid arthritis, cardiovascular disease) (<xref ref-type="bibr" rid="bib32">Luo et al., 2019</xref>; <xref ref-type="bibr" rid="bib49">Rohatgi et al., 2009</xref>). Beyond its role at time sensitization, PGLYRP-1 and many of the other specific granule proteins are dramatically reduced in serum concentration 1 week postnatal compared to cord blood and not well correlated with their cord blood concentration, suggesting an important temporal role and variation of these proteins (<xref ref-type="bibr" rid="bib39">Olin et al., 2018</xref>). This temporal variation is largely ignored in experimental approaches such as germ-line knock outs.</p><p>Although our findings contribute to our understanding of the risk for pediatric asthma, there are several limitations. Our data is derived from observational data that limits any interpretation of causation and is potentially susceptible to confounding by unmeasured variables. The findings of association between PGLYRP-1 mid-childhood asthma and adolescent FEV<sub>1</sub>/FVC were robust when adjusting for measured confounders and subset analysis. Additionally, transcription in cord blood <italic>pglyrp1</italic> in our meta-analysis and PGLYRP-1 concentration in the three cohorts was significantly associated with both sex and gestational age. This suggests that our results are plausibly generalizable to a larger population. Additionally, as with many prospective cohorts, the Project Viva cohort had increasing loss to follow up over time. At the early-teen follow up, we did not observe a significant association with current asthma. It is important to note that there was still an association between PGLYRP-1 and FEV<sub>1</sub>/FVC at this time point. These observations could be due to two possibilities. First, at early-teen follow up, there was only 9% prevalence of current asthma in the Project Viva subset, whereas the full cohort had a 15% prevalence. This difference is likely due to higher non-response rates in the asthmatic sub-group as 24 of the 35 (68%) had missing responses, whereas only 46 of 171 (27%) of non-asthmatics had missing responses. This lead to a reduction in power at the early-teen follow-up time point, potentially leading to a false negative result. Second, PGLYRP-1 might be inversely associated with FEV<sub>1</sub>/FVC in adolescence secondary to early-life pulmonary dysfunction (e.g. mid-childhood asthma). Reduced expiratory pulmonary function later in adolescences and even into adulthood is associated with individuals who were diagnosed with asthma in childhood (<xref ref-type="bibr" rid="bib4">Bui et al., 2018</xref>; <xref ref-type="bibr" rid="bib30">Lo et al., 2020</xref>; <xref ref-type="bibr" rid="bib43">Piccioni et al., 2015</xref>; <xref ref-type="bibr" rid="bib63">Turturice et al., 2017b</xref>). We view these possibilities as equally probable as current pediatric asthma can also impair FEV<sub>1</sub>/FVC (<xref ref-type="bibr" rid="bib60">Tse et al., 2013</xref>). Further investigation will be needed to elucidate the role of PGLYRP-1 in adolescent asthma.</p><p>In conclusion, we have identified a neutrophil development gene signature that is associated with perinatal asthma risk. A soluble specific granule protein, PGLYRP-1, was strongly associated with odds of asthma in childhood and pulmonary function in childhood and adolescence. This suggests that perinatal granulopoiesis has a significant impact on the development of pediatric asthma and lung function.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type (species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">Gene (<italic>Homo sapiens</italic>)</td><td valign="top"><italic>Homo sapiens</italic> Genome Assembly</td><td valign="top">Ensembl</td><td valign="top">GRCh38.12</td><td valign="top"/></tr><tr><td valign="top">Biological sample (<italic>Homo sapiens</italic>)</td><td valign="top">Primary Cord Blood Mononuclear Cells</td><td valign="top">Volunteers</td><td valign="top">UIH Cohort</td><td valign="top">Demographics reported in <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref></td></tr><tr><td valign="top">Biological sample (<italic>Homo sapiens</italic>)</td><td valign="top">Cord Blood Serum</td><td valign="top">Volunteers</td><td valign="top">UIH Cohort <break/>Project Viva</td><td valign="top">Demographics reported in <xref ref-type="supplementary-material" rid="supp5">Supplementary files 5</xref> and <xref ref-type="supplementary-material" rid="supp7">7</xref></td></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Human PGLYRP1/PGRP-S DuoSet ELISA</td><td valign="top">R and D Systems</td><td valign="top">DY2590</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Human IL6Ra DuoSet ELISA</td><td valign="top">R and D Systems</td><td valign="top">DY227</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">RNeasy Mini Kit</td><td valign="top">Qiagen</td><td valign="top">74104</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">RNA 6000 Nano Kit</td><td valign="top">Agilent</td><td valign="top">5067–1511</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Qubit RNA HS Assay Kit</td><td valign="top">Thermo Fisher Scientific</td><td valign="top">Q32852</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">TruSeq Stranded mRNA Library Prep Kit</td><td valign="top">Illumina</td><td valign="top">20020594</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">HiSeq × Ten Reagent Kit v2.5</td><td valign="top">Illumina</td><td valign="top">FC-501–2501</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">R</td><td valign="top">R</td><td valign="top">Version 3.6.3</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top"><italic>geoquery</italic></td><td valign="top">Bioconductor</td><td valign="top">Version: 2.36.0</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top"><italic>GeneMeta</italic></td><td valign="top">Bioconductor</td><td valign="top">Version: 1.54.0</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top"><italic>tximport</italic></td><td valign="top">Bioconductor</td><td valign="top">Version: 1.10.1</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top"><italic>DESeq2</italic></td><td valign="top">Bioconductor</td><td valign="top">Version: 1.22.2</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top"><italic>relaimpo</italic></td><td valign="top">CRAN</td><td valign="top">Version: 2.2–3</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top"><italic>salmon</italic></td><td valign="top">Github</td><td valign="top">Version 0.12.00</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top"><italic>GSEA</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://gsea-msigdb.org/">gsea-msigdb.org</ext-link></td><td valign="top">Version 4.0</td><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Human subject Project Viva cohort</title><p>The current study was approved by the University of Illinois at Chicago IRB (#2016–0326) and the IRB of Harvard Pilgrim Health Care. Volunteers were recruited from women attending their first prenatal visit at one of eight practices of Atrius Harvard Vanguard Medical Associates. The exclusion criteria were multiple gestation, inability to answer questions in English, gestational age ≥ 22 weeks at recruitment, and plans to move away before delivery. The cohort profile was previously described by Oken and colleagues (<xref ref-type="bibr" rid="bib38">Oken et al., 2015</xref>).</p><p>Current mid-childhood asthma was defined as a ‘yes’ response to ‘Has a health professional ever told you that your child has asthma?’ and ‘yes’ to either ‘In the past 12 months, has child taken or been prescribed Albuterol, Cromolyn, Nedocromil, Montelukast, inhaled corticosteroids, or Prednisone’ or ‘In the past 12 months, has your child ever had wheezing (or whistling in the chest)?’. We used as a comparison group those with no asthma diagnosis and no asthma medication use or wheezing in the past 12 months. We used the same definition for current asthma in early adolescence, except the time reference for asthma medication was ‘in the past month’. Ever asthma was defined as a ‘yes’ response to ‘Has a health professional ever told you that your child has asthma?’ within either the mid-childhood or early-teen follow-up periods. We used as a comparison group those with no asthma diagnosis. Individuals with missing data were not used in regression models assessing current or ever asthma outcomes. Individuals with missing data are reported in demographics tables and displayed in figure as ‘Missing Data’.</p><p>Methods for obtaining spirometric measurements and BDR have been described previously (<xref ref-type="bibr" rid="bib60">Tse et al., 2013</xref>). In brief, spirometry was performed with the EasyOne Spirometer (NDD Medical Technologies, Andover, MA). Post-bronchodilator spirometric measures were obtained at least 15 min after administration of two puffs (90 μg per puff) of albuterol. Spirometric performance was required to meet American Thoracic Society criteria for acceptability and reproducibility, with each subject producing at least three acceptable spirograms, two of which must have been reproducible (<xref ref-type="bibr" rid="bib38">Oken et al., 2015</xref>; <xref ref-type="bibr" rid="bib35">Miller, 2005</xref>).</p></sec><sec id="s4-2"><title>Human subject University of Illinois Hospital cohort</title><p>The current study was approved by the University of Illinois at Chicago IRB (#2015–0353). Women seeking prenatal care at the University of Illinois at Chicago (UIC) Center for Women’s Health were recruited as volunteers in their third trimester (29–33 weeks of gestation) between 2014 and 2017. The cohort profile has been previously described by Koenig and colleagues (<xref ref-type="bibr" rid="bib24">Koenig et al., 2020</xref>). Inclusion criteria were as follows: singleton pregnancy; naturally conceived pregnancy; 17–45 years of age; pre-pregnancy BMI ≥ 18.5; &lt;34 weeks of gestation; sufficient fluency in English to provide consent and complete the study; and ability to independently provide consent. Exclusion criteria were as follows: live birth or another pregnancy (including ectopic and molar pregnancies) in the previous 12 months; pre-eclampsia; gestational diabetes mellitus or previously diagnosed type 1 or type 2 diabetes; autoimmune disorder; current or previous premature rupture of membranes or chorioamnionitis; previous spontaneous premature birth; current bacterial or viral infection; current steroid or anti-inflammatory treatment; history of bariatric surgery; malabsorptive condition (e.g., celiac disease); current hyperemesis; hematologic disorder (e.g., sickle cell anemia or trait, hemochromatosis); current tobacco use; alcohol consumption or illicit drug use; and current use of medications that decrease nutrient absorption (e.g., proton pump inhibitors). All women provided written informed consent.</p></sec><sec id="s4-3"><title>Umbilical cord blood specimens</title><p>For Project Viva, procedures for obtaining umbilical cord blood serum have been describe previously (<xref ref-type="bibr" rid="bib51">Schaub et al., 2005</xref>). For the UIH cohort, umbilical cord blood was obtained by venipuncture shortly after time of delivery. Blood (approximately 5 mL per tube) was drawn into Red Top Serum Plus and Green Top Sodium Heparin 95 USP Units Blood Collection Tubes (BD Vacutainer). Red Tops were allowed to stand upright at room temperature for 30 min prior centrifugation at 1500 × g for 10 min at room temperature. Supernatants (serum) were collected, aliquoted, and stored at −80°C until further processing. Heparinized blood obtained in Green Tops was diluted 1:1 in 1× phosphate-buffered saline, pH 7.4 (PBS) and overlaid onto Ficoll-Paque Plus (GE Healthcare) density gradients. Density gradients were centrifuged at 400 × g for 30 min at room temperature without brake. Upper phase (diluted plasma) was drawn off, aliquoted, and stored at −80°C. Buffy coats (CBMCs) were drawn off, washed twice with 10 mL of 1× PBS, aliquoted, and stored in 500 mL of RNAlater (Qiagen). Viability and number of cells isolated were determined by diluting cellular suspensions 1:1 with Trypan Blue Solution 0.4% (wt/vol) in PBS (Corning) and counting live/dead cells &gt; 7 μM using a TC20 Automated Cell Counter (Bio-Rad). The viability of isolated cells was &gt;90% for all samples. Time from delivery to storage was recorded for every sample.</p></sec><sec id="s4-4"><title>RNA extraction and sequencing</title><p>Total RNA was extracted from CBMCs using RNeasy kits (QIAGEN) following manufacturers protocol except for switching 70% ethanol for 100% ethanol. The quality and quantity of all the extracted RNA were analyzed with a RNA 6000 Nano Kit on the 2100 Bioanalyzer Instrument (Agilent) and ssRNA High Sensitivity Kit and Qubit (Invitrogen). RIN for all samples was &gt;8. RNA was constructed into barcoded libraries using the TruSeq Stranded mRNA Library Prep Kit (Illumina). The pooled libraries were sequenced for a paired-end 151 read length. The DNA libraries were sequenced on HiSeq X Ten platform using HiSeq Reagent v2.5 kit (Illumina), following manufacturer's protocol.</p></sec><sec id="s4-5"><title>Enzyme-linked immunosorbent assays (ELISA)</title><p>PGLYRP-1 and sIL6Rα were assessed using Human PGLYRP1/PGRP-S DuoSet Elisa and Human IL-6 R alpha DuoSet Elisa (R and D Systems). Serum was diluted with 1% bovine serum albumin in PBS (pH 7.2–7.4, 0.2 micron filtered) at 1:100 for PGLYRP-1 and 1:300 for sIL6Rα. ELISAs were performed according to manufacturer’s protocol. All samples were run in duplicate. Optical densities were assessed at 450 and 540 using a Spectra Max M5 (Molecular Devices). The intra- and inter-plater CVs for PGLYRP-1 were 2.4% and 11.0%. The intra- and inter-plater CVs for sIL6Rα were 3.8% and 18.9%.</p></sec><sec id="s4-6"><title>Statistical analysis</title><p>All statistical analyses were performed in <italic>R</italic> (<ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link>) unless otherwise specified.</p></sec><sec id="s4-7"><title>Meta-analysis</title><p>To identify dataset studies used in the meta-analysis, NCBI’s Gene Expression Omnibus (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo">https://www.ncbi.nlm.nih.gov/geo</ext-link>) was searched using the search ‘(cord blood) AND ‘<italic>Homo sapiens</italic>’ [porgn:_txid9606]’ and was limited to study types that included expression profiling by array. This search yielded 352 studies that were further examined for cell types assessed and metadata reported. Seventeen studies met inclusion criteria of reporting metadata regarding at least one perinatal risk factor (e.g. gestational age at birth, newborn sex, birthweight, maternal pre-pregnancy BMI, smoke exposure, mode of delivery), and expression data from either whole cord blood or CBMCs derived from human subjects. Expression, feature, and subject demographic data were extracted using <italic>geoquery</italic> (<xref ref-type="bibr" rid="bib6">Davis and Meltzer, 2007</xref>). If expression data was non-normalized, it was quantile normalized and log2 transformed. Six studies were excluded due to no variability in demographic data (i.e. only males) or low data quality, leaving 605 unique cord blood gene expression samples. To assess associations between gene expression and perinatal risk factors, univariate, inverse variance weighted, random-effects models were constructed for genes using the <italic>GeneMeta</italic> package (<xref ref-type="bibr" rid="bib12">GeneMeta, 2020</xref>). Newborn sex (Male vs. Female), maternal pre-pregnancy BMI (continuous: 0 = BMI &lt; 18.5, 1 = 18.5 ≤ BMI &lt; 25, 2 = 25 ≤ BMI &lt; 30, 3 = 30 ≤ BMI), gestational age at birth in weeks (continuous), and birthweight in grams (continuous) were assessed as perinatal risk factors. Significant genes were defined as Benjamini–Hochberg correct p-value&lt;0.01. The z-score for each gene was averaged across each univariate test (<xref ref-type="disp-formula" rid="equ1">Equation 1</xref>) and termed pooled z-score. It was used to assess how likely a gene is effected by multiple risk factors. If a gene was not assessed in one of the univariate analyses while assessed in others, the missing data was inferred as a z-score of zero. To determine cell enrichment, genes expression in each cell as defined by HPA (<xref ref-type="bibr" rid="bib65">Uhlen et al., 2010</xref>; <xref ref-type="bibr" rid="bib36">Monaco et al., 2019</xref>) were modeled as a function of the pooled z-score using general additive model with cubic splines function. To determine biological processes enriched in the low- vs. high-risk individuals, the pooled z-score was used a pre-ranked list for gene set enrichment analysis for GO biologic processes using <italic>GSEA</italic> (<xref ref-type="bibr" rid="bib57">Subramanian et al., 2005</xref>). Significantly enriched GO terms were defined as Benjamini-Hochberg correct p-value&lt;0.01. Spearman’s correlations between pooled z-score, univariate z-scores, and individual dataset z-scores were determined in <italic>R</italic>.<disp-formula id="equ1"><label>(1)</label><mml:math id="m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi>M</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mtext> </mml:mtext><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi>P</mml:mi><mml:mi>P</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>B</mml:mi><mml:mi>M</mml:mi><mml:mi>I</mml:mi><mml:mspace width="thinmathspace"/></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mtext> </mml:mtext><mml:mo>−</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi>G</mml:mi><mml:mi>A</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mtext> </mml:mtext><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi>B</mml:mi><mml:mi>W</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mn>4</mml:mn></mml:mfrac></mml:mrow></mml:mstyle></mml:math></disp-formula></p></sec><sec id="s4-8"><title>RNA sequencing statistical analysis (UIH cohort)</title><p>The sequences were quality controlled by filtering out all low-quality reads (&lt;25 on Phred quality score) and short reads (&lt;50 bp). Transcripts were annotated using <italic>salmon v0.12.0</italic> and <italic>Ensembl Homo sapiens</italic> Genome Assembly GRCh38.12 (<xref ref-type="bibr" rid="bib42">Patro et al., 2017</xref>). Transcript counts were aggregated in gene-level counts using the <italic>tximport</italic> package in R (<xref ref-type="bibr" rid="bib55">Soneson et al., 2015</xref>). Genes with median counts across samples &lt; 10 were filtered out, leaving 14,055 genes remaining whose expression normalized using median sum scaling. Normalized gene expression was modeled as function of the number of perinatal risk factors (gestational age &lt; 37 weeks, birthweight &lt; 3000 g, PP BMI &gt;30, male) using <italic>DESeq2</italic> (<xref ref-type="bibr" rid="bib31">Love et al., 2014</xref>). Genes were ranked for replication by their product of their pooled z-score and RNAseq z-score, termed RS (<xref ref-type="disp-formula" rid="equ2">Equation 2</xref>). A cutoff of RS &gt; 3 was used to determine candidate genes associated with pediatric asthma risk. Candidate gene biologic process and cellular component enrichment were performed using STRING with default settings (<xref ref-type="bibr" rid="bib58">Szklarczyk et al., 2019</xref>). Data from RNAseq is available on NCBI SRA database ID PRJNA577955.<disp-formula id="equ2"><label>(2)</label><mml:math id="m2"><mml:msub><mml:mrow><mml:mi>R</mml:mi><mml:mi>S</mml:mi></mml:mrow><mml:mrow> <mml:mi/></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi> <mml:mi/></mml:mrow></mml:msub><mml:mo>×</mml:mo> <mml:mi/><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>q</mml:mi> <mml:mi/></mml:mrow></mml:msub></mml:math></disp-formula></p></sec><sec id="s4-9"><title>Secondary statistical analysis of mass cytometry and ProSeek data (Olin et al.)</title><p>Methods for data acquisition for cell population percentages and protein abundances using mass cytometry and ProSeek are reported by <xref ref-type="bibr" rid="bib39">Olin et al., 2018</xref>. Cell population percentages were transformed using centered log-ratios. Cell populations and protein abundances, and number of risk factors for each individual (gestational age &lt; 37 weeks, male, birthweight &lt; 3000 g, birth via c-section) were correlated (Pearson’s method). For cell population correlations with number of risk factors, significance was defined as Bonferroni corrected p-value&lt;0.05. Proteins determined to neutrophil associated were determined by those expressed in CBMC (UIH cohort) and enriched in neutrophils HPA (<xref ref-type="bibr" rid="bib65">Uhlen et al., 2010</xref>).</p></sec><sec id="s4-10"><title>Asthma and pulmonary outcome statistical analysis (Project Viva)</title><p>Outcomes assessed in Project Viva Categorical outcomes were modeled using logistic regression. Continuous outcomes were modeled using linear regression. Four regression models were used for each outcome: univariate/unadjusted model 1 adjusted for child’s demographics (gestational age at birth in weeks, birthweight adjusted for gestational age and sex, mode of delivery, sex, and race/ethnicity), model 2 adjusted for maternal demographics (PP BMI, race/ethnicity, level of education, atopy, antibiotic use during pregnancy, and smoking during pregnancy, 6 months, or 1 year), and model 3 adjusted for both mother and child’s demographics (excluding maternal race/ethnicity). For regression models, PGLYRP-1 and sIL6Rα were log10 transformed and standardized to internal z-score. Subset analysis was performed by splitting the full data set by categorical variables and modeling outcomes as function of PGLYRP-1 in each subset using the univariate model. R (<xref ref-type="bibr" rid="bib19">Jaakkola et al., 2006</xref>) for each variable in linear regression model 3 was determined using the <italic>relaimpo</italic> package (<xref ref-type="bibr" rid="bib17">Groemping, 2006</xref>). Mcfadden’s pseudo-R (<xref ref-type="bibr" rid="bib19">Jaakkola et al., 2006</xref>) for each variable in model 3 was calculated for logistic regression using full models minus the variable of interest.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>Thanks to Kelly Liesse MD, Yishin Chang MS, and Wangfei Wang MS for their helpful comments regarding this manuscript.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Validation, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Resources, Data curation, Supervision, Funding acquisition, Validation, Investigation, Methodology, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Resources, Data curation, Supervision, Validation, Investigation, Methodology, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Data curation, Funding acquisition, Investigation, Methodology, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources, Data curation, Supervision, Funding acquisition, Investigation, Methodology, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Data curation, Supervision, Funding acquisition, Investigation, Methodology, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Data curation, Formal analysis, Methodology, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Clinical trial registration NCT02820402.</p></fn><fn fn-type="other" id="fn2"><p>Human subjects: The current study was approved by the University of Illinois at Chicago IRB, 20160326 and 20150353, and the IRB of Harvard Pilgrim Health Care.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Meta-analysis of CBMC gene expression associated with newborn sex.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63745-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Meta-analysis of CBMC gene expression associated with gestational age.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63745-supp2-v2.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Meta-analysis of CBMC gene expression associated with birthweight.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63745-supp3-v2.xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Meta-analysis of CBMC gene expression associated with maternal pre-pregnancy BMI.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63745-supp4-v2.xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>UIH cohort demographics.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63745-supp5-v2.xlsx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>UIH cohort CBMC gene expression DESeq2 results.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63745-supp6-v2.xlsx"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>Project viva demographics.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63745-supp7-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-63745-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Data from RNAseq is available on NCBI Bioproject database PRJNA577955.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Turturice</surname><given-names>BA</given-names></name><collab>Theorell J</collab><name><surname>Koenig</surname><given-names>MD</given-names></name><name><surname>Tussing-Humphreys</surname><given-names>L</given-names></name><name><surname>Perkins</surname><given-names>DL</given-names></name><name><surname>Finn</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Umbilical Cord Blood Mononuclear Cell mRNAseq: UIH Cohort</data-title><source>NCBI BioProject</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA577955">PRJNA577955</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Mason</surname><given-names>E</given-names></name><name><surname>Tronc</surname><given-names>G</given-names></name><name><surname>Nones</surname><given-names>K</given-names></name><name><surname>Matigian</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Wolfinger</surname><given-names>R</given-names></name><name><surname>Wells</surname><given-names>C</given-names></name><name><surname>Gibson</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><data-title>Maternal influences on the transmission of leukocyte gene expression profiles in population samples (mother and child)</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21342">GSE21342</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Dickinson</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>CL</given-names></name><name><surname>Craigon</surname><given-names>M</given-names></name><name><surname>Ross</surname><given-names>AJ</given-names></name><name><surname>Khondoker</surname><given-names>MR</given-names></name><name><surname>Forster</surname><given-names>T</given-names></name><name><surname>Ivens</surname><given-names>A</given-names></name><name><surname>Lynn</surname><given-names>DJ</given-names></name><name><surname>Orme</surname><given-names>J</given-names></name><name><surname>Jackson</surname><given-names>A</given-names></name><name><surname>Lacaze</surname><given-names>P</given-names></name><name><surname>Stenson</surname><given-names>BJ</given-names></name><name><surname>Ghazal</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><data-title>Whole blood mRNA expression profiling of host molecular networks in neonatal sepsis</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE25504">GSE25504</pub-id></element-citation></p><p><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Votavova</surname><given-names>H</given-names></name><name><surname>Merkerova Dostalova</surname><given-names>M</given-names></name><name><surname>Fejglova</surname><given-names>K</given-names></name><name><surname>Vasikova</surname><given-names>A</given-names></name><name><surname>Krejcik</surname><given-names>Z</given-names></name><name><surname>Tabashidze</surname><given-names>N</given-names></name><name><surname>Veleminsky</surname><given-names>M Jr</given-names></name><name><surname>Pastorkova</surname><given-names>A</given-names></name><name><surname>Topinka</surname><given-names>J</given-names></name><name><surname>Sram</surname><given-names>RJ</given-names></name><name><surname>Brdicka</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><data-title>Comprehensive Study of Tobacco Smoke-Related Transcriptome Alterations in Maternal and Fetal Cells</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE27272">GSE27272</pub-id></element-citation></p><p><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Votavova</surname><given-names>H</given-names></name><name><surname>Merkerova-Dostalova</surname><given-names>M</given-names></name><name><surname>Krejcik</surname><given-names>Z</given-names></name><name><surname>Fejglova</surname><given-names>K</given-names></name><name><surname>Vasikova</surname><given-names>A</given-names></name><name><surname>Tabashidze</surname><given-names>N</given-names></name><name><surname>Pastorkova</surname><given-names>A</given-names></name><name><surname>Topinka</surname><given-names>J</given-names></name><name><surname>Balascak</surname><given-names>I</given-names></name><name><surname>Sram</surname><given-names>RJ</given-names></name><name><surname>Brdicka</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><data-title>Deregulation of Gene Expression induced by Environmental Tobacco Smoke Exposure in Pregnancy</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30032">GSE30032</pub-id></element-citation></p><p><element-citation id="dataset6" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Turan</surname><given-names>N</given-names></name><name><surname>Sapienza</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><data-title>Genome-wide analysis of gene expression levels in placenta and cord blood samples from newborns babies</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE36828">GSE36828</pub-id></element-citation></p><p><element-citation id="dataset7" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Joanna Dawn Holbrook</collab></person-group><year iso-8601-date="2012">2012</year><data-title>Transcriptome changes affecting hedgehog and cytokine signalling in the umbilical cord in late pregnancy: implications for disease risk</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE37100">GSE37100</pub-id></element-citation></p><p><element-citation id="dataset8" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Rager</surname><given-names>JE</given-names></name><name><surname>Fry</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2014">2014</year><data-title>Prenatal arsenic exposure and the epigenome: altered gene expression profiles in newborn cord blood</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE48354">GSE48354</pub-id></element-citation></p><p><element-citation id="dataset9" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Laajala</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><data-title>Standard of hygiene and immune adaptation in newborn infants</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53473">GSE53473</pub-id></element-citation></p><p><element-citation id="dataset10" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Edlow</surname><given-names>AG</given-names></name><name><surname>Hui</surname><given-names>L</given-names></name><name><surname>Wick</surname><given-names>HC</given-names></name><name><surname>Bianchi</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>The obese fetal transcriptome</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE60403">GSE60403</pub-id></element-citation></p><p><element-citation id="dataset11" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Baldwin</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Unique inflammatory transcriptome profiles at the maternal fetal interface and onset of human preterm and term birth</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73685">GSE73685</pub-id></element-citation></p><p><element-citation id="dataset12" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Winckelmans</surname><given-names>E</given-names></name><name><surname>Vrijens</surname><given-names>K</given-names></name><name><surname>Tsamou</surname><given-names>M</given-names></name><name><surname>Janssen</surname><given-names>BG</given-names></name><name><surname>Saenen</surname><given-names>ND</given-names></name><name><surname>Roels</surname><given-names>HA</given-names></name><name><surname>Kleinjans</surname><given-names>J</given-names></name><name><surname>Lefebvre</surname><given-names>W</given-names></name><name><surname>Vanpoucke</surname><given-names>C</given-names></name><name><surname>de Kok</surname><given-names>TM</given-names></name><name><surname>Nawrot</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>Newborn Sex-specific Transcriptome Signatures and Gestational Exposure to Fine Particles: Findings from the ENVIRONAGE Birth Cohort</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83393">GSE83393</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azad</surname> <given-names>MB</given-names></name><name><surname>Coneys</surname> <given-names>JG</given-names></name><name><surname>Kozyrskyj</surname> <given-names>AL</given-names></name><name><surname>Field</surname> <given-names>CJ</given-names></name><name><surname>Ramsey</surname> <given-names>CD</given-names></name><name><surname>Becker</surname> <given-names>AB</given-names></name><name><surname>Friesen</surname> <given-names>C</given-names></name><name><surname>Abou-Setta</surname> <given-names>AM</given-names></name><name><surname>Zarychanski</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis</article-title><source>BMJ</source><volume>347</volume><elocation-id>f6471</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.f6471</pub-id><pub-id pub-id-type="pmid">24304677</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisgaard</surname> <given-names>H</given-names></name><name><surname>Bønnelykke</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Long-term studies of the natural history of asthma in childhood</article-title><source>Journal of Allergy and Clinical Immunology</source><volume>126</volume><fpage>187</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2010.07.011</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohlin</surname> <given-names>J</given-names></name><name><surname>Håberg</surname> <given-names>SE</given-names></name><name><surname>Magnus</surname> <given-names>P</given-names></name><name><surname>Reese</surname> <given-names>SE</given-names></name><name><surname>Gjessing</surname> <given-names>HK</given-names></name><name><surname>Magnus</surname> <given-names>MC</given-names></name><name><surname>Parr</surname> <given-names>CL</given-names></name><name><surname>Page</surname> <given-names>CM</given-names></name><name><surname>London</surname> <given-names>SJ</given-names></name><name><surname>Nystad</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Prediction of gestational age based on genome-wide differentially methylated regions</article-title><source>Genome Biology</source><volume>17</volume><elocation-id>207</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-016-1063-4</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bui</surname> <given-names>DS</given-names></name><name><surname>Lodge</surname> <given-names>CJ</given-names></name><name><surname>Burgess</surname> <given-names>JA</given-names></name><name><surname>Lowe</surname> <given-names>AJ</given-names></name><name><surname>Perret</surname> <given-names>J</given-names></name><name><surname>Bui</surname> <given-names>MQ</given-names></name><name><surname>Bowatte</surname> <given-names>G</given-names></name><name><surname>Gurrin</surname> <given-names>L</given-names></name><name><surname>Johns</surname> <given-names>DP</given-names></name><name><surname>Thompson</surname> <given-names>BR</given-names></name><name><surname>Hamilton</surname> <given-names>GS</given-names></name><name><surname>Frith</surname> <given-names>PA</given-names></name><name><surname>James</surname> <given-names>AL</given-names></name><name><surname>Thomas</surname> <given-names>PS</given-names></name><name><surname>Jarvis</surname> <given-names>D</given-names></name><name><surname>Svanes</surname> <given-names>C</given-names></name><name><surname>Russell</surname> <given-names>M</given-names></name><name><surname>Morrison</surname> <given-names>SC</given-names></name><name><surname>Feather</surname> <given-names>I</given-names></name><name><surname>Allen</surname> <given-names>KJ</given-names></name><name><surname>Wood-Baker</surname> <given-names>R</given-names></name><name><surname>Hopper</surname> <given-names>J</given-names></name><name><surname>Giles</surname> <given-names>GG</given-names></name><name><surname>Abramson</surname> <given-names>MJ</given-names></name><name><surname>Walters</surname> <given-names>EH</given-names></name><name><surname>Matheson</surname> <given-names>MC</given-names></name><name><surname>Dharmage</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life</article-title><source>The Lancet Respiratory Medicine</source><volume>6</volume><fpage>535</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(18)30100-0</pub-id><pub-id pub-id-type="pmid">29628376</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bukowski</surname> <given-names>R</given-names></name><name><surname>Sadovsky</surname> <given-names>Y</given-names></name><name><surname>Goodarzi</surname> <given-names>H</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Biggio</surname> <given-names>JR</given-names></name><name><surname>Varner</surname> <given-names>M</given-names></name><name><surname>Parry</surname> <given-names>S</given-names></name><name><surname>Xiao</surname> <given-names>F</given-names></name><name><surname>Esplin</surname> <given-names>SM</given-names></name><name><surname>Andrews</surname> <given-names>W</given-names></name><name><surname>Saade</surname> <given-names>GR</given-names></name><name><surname>Ilekis</surname> <given-names>JV</given-names></name><name><surname>Reddy</surname> <given-names>UM</given-names></name><name><surname>Baldwin</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Onset of human preterm and term birth is related to unique inflammatory transcriptome profiles at the maternal fetal interface</article-title><source>PeerJ</source><volume>5</volume><elocation-id>e3685</elocation-id><pub-id pub-id-type="doi">10.7717/peerj.3685</pub-id><pub-id pub-id-type="pmid">28879060</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>S</given-names></name><name><surname>Meltzer</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>GEOquery: a bridge between the gene expression omnibus (GEO) and BioConductor</article-title><source>Bioinformatics</source><volume>23</volume><fpage>1846</fpage><lpage>1847</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btm254</pub-id><pub-id pub-id-type="pmid">17496320</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>den Dekker</surname> <given-names>HT</given-names></name><name><surname>Burrows</surname> <given-names>K</given-names></name><name><surname>Felix</surname> <given-names>JF</given-names></name><name><surname>Salas</surname> <given-names>LA</given-names></name><name><surname>Nedeljkovic</surname> <given-names>I</given-names></name><name><surname>Yao</surname> <given-names>J</given-names></name><name><surname>Rifas-Shiman</surname> <given-names>SL</given-names></name><name><surname>Ruiz-Arenas</surname> <given-names>C</given-names></name><name><surname>Amin</surname> <given-names>N</given-names></name><name><surname>Bustamante</surname> <given-names>M</given-names></name><name><surname>DeMeo</surname> <given-names>DL</given-names></name><name><surname>Henderson</surname> <given-names>AJ</given-names></name><name><surname>Howe</surname> <given-names>CG</given-names></name><name><surname>Hivert</surname> <given-names>M-F</given-names></name><name><surname>Ikram</surname> <given-names>MA</given-names></name><name><surname>de Jongste</surname> <given-names>JC</given-names></name><name><surname>Lahousse</surname> <given-names>L</given-names></name><name><surname>Mandaviya</surname> <given-names>PR</given-names></name><name><surname>van Meurs</surname> <given-names>JB</given-names></name><name><surname>Pinart</surname> <given-names>M</given-names></name><name><surname>Sharp</surname> <given-names>GC</given-names></name><name><surname>Stolk</surname> <given-names>L</given-names></name><name><surname>Uitterlinden</surname> <given-names>AG</given-names></name><name><surname>Anto</surname> <given-names>JM</given-names></name><name><surname>Litonjua</surname> <given-names>AA</given-names></name><name><surname>Breton</surname> <given-names>CV</given-names></name><name><surname>Brusselle</surname> <given-names>GG</given-names></name><name><surname>Sunyer</surname> <given-names>J</given-names></name><name><surname>Smith</surname> <given-names>GD</given-names></name><name><surname>Relton</surname> <given-names>CL</given-names></name><name><surname>Jaddoe</surname> <given-names>VWV</given-names></name><name><surname>Duijts</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Newborn DNA-methylation, childhood lung function, and the risks of asthma and COPD across the life course</article-title><source>European Respiratory Journal</source><volume>53</volume><elocation-id>1801795</elocation-id><pub-id pub-id-type="doi">10.1183/13993003.01795-2018</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dziarski</surname> <given-names>R</given-names></name><name><surname>Platt</surname> <given-names>KA</given-names></name><name><surname>Gelius</surname> <given-names>E</given-names></name><name><surname>Steiner</surname> <given-names>H</given-names></name><name><surname>Gupta</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Defect in neutrophil killing and increased susceptibility to infection with nonpathogenic gram-positive Bacteria in peptidoglycan recognition protein-S (PGRP-S)-deficient mice</article-title><source>Blood</source><volume>102</volume><fpage>689</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1182/blood-2002-12-3853</pub-id><pub-id pub-id-type="pmid">12649138</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dziarski</surname> <given-names>R</given-names></name><name><surname>Gupta</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The peptidoglycan recognition proteins (PGRPs)</article-title><source>Genome Biology</source><volume>7</volume><elocation-id>232</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2006-7-8-232</pub-id><pub-id pub-id-type="pmid">16930467</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edlow</surname> <given-names>AG</given-names></name><name><surname>Hui</surname> <given-names>L</given-names></name><name><surname>Wick</surname> <given-names>HC</given-names></name><name><surname>Fried</surname> <given-names>I</given-names></name><name><surname>Bianchi</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Assessing the fetal effects of maternal obesity via transcriptomic analysis of cord blood: a prospective case-control study</article-title><source>BJOG: An International Journal of Obstetrics &amp; Gynaecology</source><volume>123</volume><fpage>180</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1111/1471-0528.13795</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forestier</surname> <given-names>F</given-names></name><name><surname>Daffos</surname> <given-names>F</given-names></name><name><surname>Catherine</surname> <given-names>N</given-names></name><name><surname>Renard</surname> <given-names>M</given-names></name><name><surname>Andreux</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Developmental hematopoiesis in normal human fetal blood</article-title><source>Blood</source><volume>77</volume><fpage>2360</fpage><lpage>2363</lpage><pub-id pub-id-type="doi">10.1182/blood.V77.11.2360.2360</pub-id><pub-id pub-id-type="pmid">2039818</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="software"><person-group person-group-type="author"><collab>GeneMeta</collab></person-group><year iso-8601-date="2020">2020</year><data-title>MetaAnalysis for High Throughput Experiments [computer program]</data-title><source>Version R Package Version</source><version designator="3.12">3.12</version><ext-link ext-link-type="uri" xlink:href="https://www.bioconductor.org/packages/release/bioc/html/GeneMeta.html">https://www.bioconductor.org/packages/release/bioc/html/GeneMeta.html</ext-link></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname> <given-names>A</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Dziarski</surname> <given-names>R</given-names></name><name><surname>Chakravarti</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A novel antimicrobial peptidoglycan recognition protein in the cornea</article-title><source>Investigative Opthalmology &amp; Visual Science</source><volume>50</volume><fpage>4185</fpage><lpage>4191</lpage><pub-id pub-id-type="doi">10.1167/iovs.08-3040</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbons</surname> <given-names>D</given-names></name><name><surname>Fleming</surname> <given-names>P</given-names></name><name><surname>Virasami</surname> <given-names>A</given-names></name><name><surname>Michel</surname> <given-names>ML</given-names></name><name><surname>Sebire</surname> <given-names>NJ</given-names></name><name><surname>Costeloe</surname> <given-names>K</given-names></name><name><surname>Carr</surname> <given-names>R</given-names></name><name><surname>Klein</surname> <given-names>N</given-names></name><name><surname>Hayday</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants</article-title><source>Nature Medicine</source><volume>20</volume><fpage>1206</fpage><lpage>1210</lpage><pub-id pub-id-type="doi">10.1038/nm.3670</pub-id><pub-id pub-id-type="pmid">25242415</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glasser</surname> <given-names>L</given-names></name><name><surname>Sutton</surname> <given-names>N</given-names></name><name><surname>Schmeling</surname> <given-names>M</given-names></name><name><surname>Machan</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A comprehensive study of umbilical cord blood cell developmental changes and reference ranges by gestation, gender and mode of delivery</article-title><source>Journal of Perinatology</source><volume>35</volume><fpage>469</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1038/jp.2014.241</pub-id><pub-id pub-id-type="pmid">25634517</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grassi</surname> <given-names>L</given-names></name><name><surname>Pourfarzad</surname> <given-names>F</given-names></name><name><surname>Ullrich</surname> <given-names>S</given-names></name><name><surname>Merkel</surname> <given-names>A</given-names></name><name><surname>Were</surname> <given-names>F</given-names></name><name><surname>Carrillo-de-Santa-Pau</surname> <given-names>E</given-names></name><name><surname>Yi</surname> <given-names>G</given-names></name><name><surname>Hiemstra</surname> <given-names>IH</given-names></name><name><surname>Tool</surname> <given-names>ATJ</given-names></name><name><surname>Mul</surname> <given-names>E</given-names></name><name><surname>Perner</surname> <given-names>J</given-names></name><name><surname>Janssen-Megens</surname> <given-names>E</given-names></name><name><surname>Berentsen</surname> <given-names>K</given-names></name><name><surname>Kerstens</surname> <given-names>H</given-names></name><name><surname>Habibi</surname> <given-names>E</given-names></name><name><surname>Gut</surname> <given-names>M</given-names></name><name><surname>Yaspo</surname> <given-names>ML</given-names></name><name><surname>Linser</surname> <given-names>M</given-names></name><name><surname>Lowy</surname> <given-names>E</given-names></name><name><surname>Datta</surname> <given-names>A</given-names></name><name><surname>Clarke</surname> <given-names>L</given-names></name><name><surname>Flicek</surname> <given-names>P</given-names></name><name><surname>Vingron</surname> <given-names>M</given-names></name><name><surname>Roos</surname> <given-names>D</given-names></name><name><surname>van den Berg</surname> <given-names>TK</given-names></name><name><surname>Heath</surname> <given-names>S</given-names></name><name><surname>Rico</surname> <given-names>D</given-names></name><name><surname>Frontini</surname> <given-names>M</given-names></name><name><surname>Kostadima</surname> <given-names>M</given-names></name><name><surname>Gut</surname> <given-names>I</given-names></name><name><surname>Valencia</surname> <given-names>A</given-names></name><name><surname>Ouwehand</surname> <given-names>WH</given-names></name><name><surname>Stunnenberg</surname> <given-names>HG</given-names></name><name><surname>Martens</surname> <given-names>JHA</given-names></name><name><surname>Kuijpers</surname> <given-names>TW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Dynamics of transcription regulation in human bone marrow myeloid differentiation to mature blood neutrophils</article-title><source>Cell Reports</source><volume>24</volume><fpage>2784</fpage><lpage>2794</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.08.018</pub-id><pub-id pub-id-type="pmid">30184510</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Groemping</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Relative importance for linear regression in R</article-title><conf-name>The Package Relaimpo</conf-name><pub-id pub-id-type="doi">10.18637/jss.v017.i01</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname> <given-names>A</given-names></name><name><surname>Arora</surname> <given-names>G</given-names></name><name><surname>Rosen</surname> <given-names>CE</given-names></name><name><surname>Kloos</surname> <given-names>Z</given-names></name><name><surname>Cao</surname> <given-names>Y</given-names></name><name><surname>Cerny</surname> <given-names>J</given-names></name><name><surname>Sajid</surname> <given-names>A</given-names></name><name><surname>Hoornstra</surname> <given-names>D</given-names></name><name><surname>Golovchenko</surname> <given-names>M</given-names></name><name><surname>Rudenko</surname> <given-names>N</given-names></name><name><surname>Munderloh</surname> <given-names>U</given-names></name><name><surname>Hovius</surname> <given-names>JW</given-names></name><name><surname>Booth</surname> <given-names>CJ</given-names></name><name><surname>Jacobs-Wagner</surname> <given-names>C</given-names></name><name><surname>Palm</surname> <given-names>NW</given-names></name><name><surname>Ring</surname> <given-names>AM</given-names></name><name><surname>Fikrig</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A human secretome library screen reveals a role for peptidoglycan recognition protein 1 in lyme borreliosis</article-title><source>PLOS Pathogens</source><volume>16</volume><elocation-id>e1009030</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1009030</pub-id><pub-id pub-id-type="pmid">33175909</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaakkola</surname> <given-names>J</given-names></name><name><surname>Ahmed</surname> <given-names>P</given-names></name><name><surname>Ieromnimon</surname> <given-names>A</given-names></name><name><surname>Goepfert</surname> <given-names>P</given-names></name><name><surname>Laiou</surname> <given-names>E</given-names></name><name><surname>Quansah</surname> <given-names>R</given-names></name><name><surname>Jaakkola</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Preterm delivery and asthma: a systematic review and meta-analysis</article-title><source>Journal of Allergy and Clinical Immunology</source><volume>118</volume><fpage>823</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2006.06.043</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>SA</given-names></name><name><surname>Horiuchi</surname> <given-names>S</given-names></name><name><surname>Topley</surname> <given-names>N</given-names></name><name><surname>Yamamoto</surname> <given-names>N</given-names></name><name><surname>Fuller</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The soluble interleukin 6 receptor: mechanisms of production and implications in disease</article-title><source>The FASEB Journal</source><volume>15</volume><fpage>43</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1096/fj.99-1003rev</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallionpää</surname> <given-names>H</given-names></name><name><surname>Laajala</surname> <given-names>E</given-names></name><name><surname>Öling</surname> <given-names>V</given-names></name><name><surname>Härkönen</surname> <given-names>T</given-names></name><name><surname>Tillmann</surname> <given-names>V</given-names></name><name><surname>Dorshakova</surname> <given-names>NV</given-names></name><name><surname>Ilonen</surname> <given-names>J</given-names></name><name><surname>Lähdesmäki</surname> <given-names>H</given-names></name><name><surname>Knip</surname> <given-names>M</given-names></name><name><surname>Lahesmaa</surname> <given-names>R</given-names></name><collab>DIABIMMUNE Study Group</collab></person-group><year iso-8601-date="2014">2014</year><article-title>Standard of hygiene and immune adaptation in newborn infants</article-title><source>Clinical Immunology</source><volume>155</volume><fpage>136</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1016/j.clim.2014.09.009</pub-id><pub-id pub-id-type="pmid">25245264</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashyap</surname> <given-names>DR</given-names></name><name><surname>Wang</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>LH</given-names></name><name><surname>Boons</surname> <given-names>GJ</given-names></name><name><surname>Gupta</surname> <given-names>D</given-names></name><name><surname>Dziarski</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Peptidoglycan recognition proteins kill Bacteria by activating protein-sensing two-component systems</article-title><source>Nature Medicine</source><volume>17</volume><fpage>676</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1038/nm.2357</pub-id><pub-id pub-id-type="pmid">21602801</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klimenkova</surname> <given-names>O</given-names></name><name><surname>Ellerbeck</surname> <given-names>W</given-names></name><name><surname>Klimiankou</surname> <given-names>M</given-names></name><name><surname>Ünalan</surname> <given-names>M</given-names></name><name><surname>Kandabarau</surname> <given-names>S</given-names></name><name><surname>Gigina</surname> <given-names>A</given-names></name><name><surname>Hussein</surname> <given-names>K</given-names></name><name><surname>Zeidler</surname> <given-names>C</given-names></name><name><surname>Welte</surname> <given-names>K</given-names></name><name><surname>Skokowa</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation</article-title><source>Blood</source><volume>123</volume><fpage>1239</fpage><lpage>1249</lpage><pub-id pub-id-type="doi">10.1182/blood-2013-06-508887</pub-id><pub-id pub-id-type="pmid">24352879</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koenig</surname> <given-names>MD</given-names></name><name><surname>Klikuszowian</surname> <given-names>E</given-names></name><name><surname>O'Brien</surname> <given-names>KO</given-names></name><name><surname>Pauls</surname> <given-names>H</given-names></name><name><surname>Steffen</surname> <given-names>A</given-names></name><name><surname>DeMartelly</surname> <given-names>V</given-names></name><name><surname>Ruchob</surname> <given-names>R</given-names></name><name><surname>Welke</surname> <given-names>L</given-names></name><name><surname>Hemphill</surname> <given-names>N</given-names></name><name><surname>LaBomascus</surname> <given-names>B</given-names></name><name><surname>Pezley</surname> <given-names>L</given-names></name><name><surname>McLeod</surname> <given-names>A</given-names></name><name><surname>Hirsch</surname> <given-names>B</given-names></name><name><surname>Ferrans</surname> <given-names>CE</given-names></name><name><surname>Tussing-Humphreys</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Prepregnancy obesity is not associated with iron utilization during the third trimester</article-title><source>The Journal of Nutrition</source><volume>150</volume><fpage>1397</fpage><lpage>1404</lpage><pub-id pub-id-type="doi">10.1093/jn/nxaa065</pub-id><pub-id pub-id-type="pmid">32221605</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname> <given-names>SM</given-names></name><name><surname>Corriden</surname> <given-names>R</given-names></name><name><surname>Nizet</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Age-Appropriate functions and dysfunctions of the neonatal neutrophil</article-title><source>Frontiers in Pediatrics</source><volume>5</volume><elocation-id>23</elocation-id><pub-id pub-id-type="doi">10.3389/fped.2017.00023</pub-id><pub-id pub-id-type="pmid">28293548</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lekstrom-Himes</surname> <given-names>JA</given-names></name><name><surname>Dorman</surname> <given-names>SE</given-names></name><name><surname>Kopar</surname> <given-names>P</given-names></name><name><surname>Holland</surname> <given-names>SM</given-names></name><name><surname>Gallin</surname> <given-names>JI</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/Enhancer binding protein ε</article-title><source>Journal of Experimental Medicine</source><volume>189</volume><fpage>1847</fpage><lpage>1852</lpage><pub-id pub-id-type="doi">10.1084/jem.189.11.1847</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>H</given-names></name><name><surname>Mosmann</surname> <given-names>TR</given-names></name><name><surname>Guilbert</surname> <given-names>L</given-names></name><name><surname>Tuntipopipat</surname> <given-names>S</given-names></name><name><surname>Wegmann</surname> <given-names>TG</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Synthesis of T helper 2-type cytokines at the maternal-fetal interface</article-title><source>Journal of Immunology</source><volume>151</volume><fpage>4562</fpage><lpage>4573</lpage><pub-id pub-id-type="pmid">8409418</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litonjua</surname> <given-names>AA</given-names></name><name><surname>Carey</surname> <given-names>VJ</given-names></name><name><surname>Laranjo</surname> <given-names>N</given-names></name><name><surname>Stubbs</surname> <given-names>BJ</given-names></name><name><surname>Mirzakhani</surname> <given-names>H</given-names></name><name><surname>O’Connor</surname> <given-names>GT</given-names></name><name><surname>Sandel</surname> <given-names>M</given-names></name><name><surname>Beigelman</surname> <given-names>A</given-names></name><name><surname>Bacharier</surname> <given-names>LB</given-names></name><name><surname>Zeiger</surname> <given-names>RS</given-names></name><name><surname>Schatz</surname> <given-names>M</given-names></name><name><surname>Hollis</surname> <given-names>BW</given-names></name><name><surname>Weiss</surname> <given-names>ST</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Six-Year Follow-up of a trial of antenatal vitamin D for asthma reduction</article-title><source>New England Journal of Medicine</source><volume>382</volume><fpage>525</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1906137</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>C</given-names></name><name><surname>Gelius</surname> <given-names>E</given-names></name><name><surname>Liu</surname> <given-names>G</given-names></name><name><surname>Steiner</surname> <given-names>H</given-names></name><name><surname>Dziarski</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Mammalian peptidoglycan recognition protein binds peptidoglycan with high affinity, is expressed in neutrophils, and inhibits bacterial growth</article-title><source>Journal of Biological Chemistry</source><volume>275</volume><fpage>24490</fpage><lpage>24499</lpage><pub-id pub-id-type="doi">10.1074/jbc.M001239200</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname> <given-names>DK</given-names></name><name><surname>Beardsmore</surname> <given-names>CS</given-names></name><name><surname>Roland</surname> <given-names>D</given-names></name><name><surname>Richardson</surname> <given-names>M</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Danvers</surname> <given-names>L</given-names></name><name><surname>Wilson</surname> <given-names>A</given-names></name><name><surname>Gaillard</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Lung function and asthma control in school-age children managed in UK primary care: a cohort study</article-title><source>Thorax</source><volume>75</volume><fpage>101</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2019-213068</pub-id><pub-id pub-id-type="pmid">31666388</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Anders</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>Q</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Yao</surname> <given-names>F</given-names></name><name><surname>Deng</surname> <given-names>Z</given-names></name><name><surname>Qing</surname> <given-names>C</given-names></name><name><surname>Su</surname> <given-names>R</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Guo</surname> <given-names>Y</given-names></name><name><surname>Huang</surname> <given-names>Z</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Serum PGLYRP1 is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis</article-title><source>Molecular Medicine Reports</source><volume>19</volume><fpage>589</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.3892/mmr.2018.9632</pub-id><pub-id pub-id-type="pmid">30431075</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ly</surname> <given-names>NP</given-names></name><name><surname>Rifas-Shiman</surname> <given-names>SL</given-names></name><name><surname>Litonjua</surname> <given-names>AA</given-names></name><name><surname>Tzianabos</surname> <given-names>AO</given-names></name><name><surname>Schaub</surname> <given-names>B</given-names></name><name><surname>Ruiz-Pérez</surname> <given-names>B</given-names></name><name><surname>Tantisira</surname> <given-names>KG</given-names></name><name><surname>Finn</surname> <given-names>PW</given-names></name><name><surname>Gillman</surname> <given-names>MW</given-names></name><name><surname>Weiss</surname> <given-names>ST</given-names></name><name><surname>Gold</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Cord blood cytokines and acute lower respiratory illnesses in the first year of life</article-title><source>Pediatrics</source><volume>119</volume><fpage>e171</fpage><lpage>e178</lpage><pub-id pub-id-type="doi">10.1542/peds.2006-0524</pub-id><pub-id pub-id-type="pmid">17145902</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mason</surname> <given-names>E</given-names></name><name><surname>Tronc</surname> <given-names>G</given-names></name><name><surname>Nones</surname> <given-names>K</given-names></name><name><surname>Matigian</surname> <given-names>N</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Aronow</surname> <given-names>BJ</given-names></name><name><surname>Wolfinger</surname> <given-names>RD</given-names></name><name><surname>Wells</surname> <given-names>C</given-names></name><name><surname>Gibson</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Maternal influences on the transmission of leukocyte gene expression profiles in population samples from Brisbane, Australia</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e14479</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0014479</pub-id><pub-id pub-id-type="pmid">21217831</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Standardisation of spirometry</article-title><source>European Respiratory Journal</source><volume>26</volume><fpage>319</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1183/09031936.05.00034805</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monaco</surname> <given-names>G</given-names></name><name><surname>Lee</surname> <given-names>B</given-names></name><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Mustafah</surname> <given-names>S</given-names></name><name><surname>Hwang</surname> <given-names>YY</given-names></name><name><surname>Carré</surname> <given-names>C</given-names></name><name><surname>Burdin</surname> <given-names>N</given-names></name><name><surname>Visan</surname> <given-names>L</given-names></name><name><surname>Ceccarelli</surname> <given-names>M</given-names></name><name><surname>Poidinger</surname> <given-names>M</given-names></name><name><surname>Zippelius</surname> <given-names>A</given-names></name><name><surname>Pedro de Magalhães</surname> <given-names>J</given-names></name><name><surname>Larbi</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>RNA-Seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types</article-title><source>Cell Reports</source><volume>26</volume><fpage>1627</fpage><lpage>1640</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.01.041</pub-id><pub-id pub-id-type="pmid">30726743</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu</surname> <given-names>M</given-names></name><name><surname>Ye</surname> <given-names>S</given-names></name><name><surname>Bai</surname> <given-names>M-J</given-names></name><name><surname>Liu</surname> <given-names>G-L</given-names></name><name><surname>Tong</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>S-F</given-names></name><name><surname>Sheng</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Birth weight and subsequent risk of asthma: a systematic review and Meta-Analysis</article-title><source>Heart, Lung and Circulation</source><volume>23</volume><fpage>511</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1016/j.hlc.2013.11.018</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oken</surname> <given-names>E</given-names></name><name><surname>Baccarelli</surname> <given-names>AA</given-names></name><name><surname>Gold</surname> <given-names>DR</given-names></name><name><surname>Kleinman</surname> <given-names>KP</given-names></name><name><surname>Litonjua</surname> <given-names>AA</given-names></name><name><surname>De Meo</surname> <given-names>D</given-names></name><name><surname>Rich-Edwards</surname> <given-names>JW</given-names></name><name><surname>Rifas-Shiman</surname> <given-names>SL</given-names></name><name><surname>Sagiv</surname> <given-names>S</given-names></name><name><surname>Taveras</surname> <given-names>EM</given-names></name><name><surname>Weiss</surname> <given-names>ST</given-names></name><name><surname>Belfort</surname> <given-names>MB</given-names></name><name><surname>Burris</surname> <given-names>HH</given-names></name><name><surname>Camargo</surname> <given-names>CA</given-names></name><name><surname>Huh</surname> <given-names>SY</given-names></name><name><surname>Mantzoros</surname> <given-names>C</given-names></name><name><surname>Parker</surname> <given-names>MG</given-names></name><name><surname>Gillman</surname> <given-names>MW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cohort profile: project viva</article-title><source>International Journal of Epidemiology</source><volume>44</volume><fpage>37</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1093/ije/dyu008</pub-id><pub-id pub-id-type="pmid">24639442</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olin</surname> <given-names>A</given-names></name><name><surname>Henckel</surname> <given-names>E</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Lakshmikanth</surname> <given-names>T</given-names></name><name><surname>Pou</surname> <given-names>C</given-names></name><name><surname>Mikes</surname> <given-names>J</given-names></name><name><surname>Gustafsson</surname> <given-names>A</given-names></name><name><surname>Bernhardsson</surname> <given-names>AK</given-names></name><name><surname>Zhang</surname> <given-names>C</given-names></name><name><surname>Bohlin</surname> <given-names>K</given-names></name><name><surname>Brodin</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Stereotypic immune system development in newborn children</article-title><source>Cell</source><volume>174</volume><fpage>1277</fpage><lpage>1292</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.06.045</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osanai</surname> <given-names>A</given-names></name><name><surname>Sashinami</surname> <given-names>H</given-names></name><name><surname>Asano</surname> <given-names>K</given-names></name><name><surname>Li</surname> <given-names>SJ</given-names></name><name><surname>Hu</surname> <given-names>DL</given-names></name><name><surname>Nakane</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mouse peptidoglycan recognition protein PGLYRP-1 plays a role in the host innate immune response against <italic>Listeria monocytogenes</italic> infection</article-title><source>Infection and Immunity</source><volume>79</volume><fpage>858</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1128/IAI.00466-10</pub-id><pub-id pub-id-type="pmid">21134971</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>SY</given-names></name><name><surname>Jing</surname> <given-names>X</given-names></name><name><surname>Gupta</surname> <given-names>D</given-names></name><name><surname>Dziarski</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Peptidoglycan recognition protein 1 enhances experimental asthma by promoting Th2 and Th17 and limiting regulatory T cell and plasmacytoid dendritic cell responses</article-title><source>The Journal of Immunology</source><volume>190</volume><fpage>3480</fpage><lpage>3492</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1202675</pub-id><pub-id pub-id-type="pmid">23420883</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patro</surname> <given-names>R</given-names></name><name><surname>Duggal</surname> <given-names>G</given-names></name><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Irizarry</surname> <given-names>RA</given-names></name><name><surname>Kingsford</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Salmon provides fast and bias-aware quantification of transcript expression</article-title><source>Nature Methods</source><volume>14</volume><fpage>417</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4197</pub-id><pub-id pub-id-type="pmid">28263959</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piccioni</surname> <given-names>P</given-names></name><name><surname>Tassinari</surname> <given-names>R</given-names></name><name><surname>Carosso</surname> <given-names>A</given-names></name><name><surname>Carena</surname> <given-names>C</given-names></name><name><surname>Bugiani</surname> <given-names>M</given-names></name><name><surname>Bono</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Lung function changes from childhood to adolescence: a seven-year follow-up study</article-title><source>BMC Pulmonary Medicine</source><volume>15</volume><elocation-id>31</elocation-id><pub-id pub-id-type="doi">10.1186/s12890-015-0028-9</pub-id><pub-id pub-id-type="pmid">25885675</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rager</surname> <given-names>JE</given-names></name><name><surname>Bailey</surname> <given-names>KA</given-names></name><name><surname>Smeester</surname> <given-names>L</given-names></name><name><surname>Miller</surname> <given-names>SK</given-names></name><name><surname>Parker</surname> <given-names>JS</given-names></name><name><surname>Laine</surname> <given-names>JE</given-names></name><name><surname>Drobná</surname> <given-names>Z</given-names></name><name><surname>Currier</surname> <given-names>J</given-names></name><name><surname>Douillet</surname> <given-names>C</given-names></name><name><surname>Olshan</surname> <given-names>AF</given-names></name><name><surname>Rubio-Andrade</surname> <given-names>M</given-names></name><name><surname>Stýblo</surname> <given-names>M</given-names></name><name><surname>García-Vargas</surname> <given-names>G</given-names></name><name><surname>Fry</surname> <given-names>RC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Prenatal arsenic exposure and the epigenome: altered microRNAs associated with innate and adaptive immune signaling in newborn cord blood</article-title><source>Environmental and Molecular Mutagenesis</source><volume>55</volume><fpage>196</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1002/em.21842</pub-id><pub-id pub-id-type="pmid">24327377</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Read</surname> <given-names>CB</given-names></name><name><surname>Kuijper</surname> <given-names>JL</given-names></name><name><surname>Hjorth</surname> <given-names>SA</given-names></name><name><surname>Heipel</surname> <given-names>MD</given-names></name><name><surname>Tang</surname> <given-names>X</given-names></name><name><surname>Fleetwood</surname> <given-names>AJ</given-names></name><name><surname>Dantzler</surname> <given-names>JL</given-names></name><name><surname>Grell</surname> <given-names>SN</given-names></name><name><surname>Kastrup</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Brandt</surname> <given-names>CS</given-names></name><name><surname>Hansen</surname> <given-names>AJ</given-names></name><name><surname>Wagtmann</surname> <given-names>NR</given-names></name><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Stennicke</surname> <given-names>VW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cutting edge: identification of neutrophil PGLYRP1 as a ligand for TREM-1</article-title><source>The Journal of Immunology</source><volume>194</volume><fpage>1417</fpage><lpage>1421</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1402303</pub-id><pub-id pub-id-type="pmid">25595774</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reese</surname> <given-names>SE</given-names></name><name><surname>Xu</surname> <given-names>C-J</given-names></name><name><surname>den Dekker</surname> <given-names>HT</given-names></name><name><surname>Lee</surname> <given-names>MK</given-names></name><name><surname>Sikdar</surname> <given-names>S</given-names></name><name><surname>Ruiz-Arenas</surname> <given-names>C</given-names></name><name><surname>Merid</surname> <given-names>SK</given-names></name><name><surname>Rezwan</surname> <given-names>FI</given-names></name><name><surname>Page</surname> <given-names>CM</given-names></name><name><surname>Ullemar</surname> <given-names>V</given-names></name><name><surname>Melton</surname> <given-names>PE</given-names></name><name><surname>Oh</surname> <given-names>SS</given-names></name><name><surname>Yang</surname> <given-names>IV</given-names></name><name><surname>Burrows</surname> <given-names>K</given-names></name><name><surname>Söderhäll</surname> <given-names>C</given-names></name><name><surname>Jima</surname> <given-names>DD</given-names></name><name><surname>Gao</surname> <given-names>L</given-names></name><name><surname>Arathimos</surname> <given-names>R</given-names></name><name><surname>Küpers</surname> <given-names>LK</given-names></name><name><surname>Wielscher</surname> <given-names>M</given-names></name><name><surname>Rzehak</surname> <given-names>P</given-names></name><name><surname>Lahti</surname> <given-names>J</given-names></name><name><surname>Laprise</surname> <given-names>C</given-names></name><name><surname>Madore</surname> <given-names>A-M</given-names></name><name><surname>Ward</surname> <given-names>J</given-names></name><name><surname>Bennett</surname> <given-names>BD</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Bell</surname> <given-names>DA</given-names></name><name><surname>Vonk</surname> <given-names>JM</given-names></name><name><surname>Håberg</surname> <given-names>SE</given-names></name><name><surname>Zhao</surname> <given-names>S</given-names></name><name><surname>Karlsson</surname> <given-names>R</given-names></name><name><surname>Hollams</surname> <given-names>E</given-names></name><name><surname>Hu</surname> <given-names>D</given-names></name><name><surname>Richards</surname> <given-names>AJ</given-names></name><name><surname>Bergström</surname> <given-names>A</given-names></name><name><surname>Sharp</surname> <given-names>GC</given-names></name><name><surname>Felix</surname> <given-names>JF</given-names></name><name><surname>Bustamante</surname> <given-names>M</given-names></name><name><surname>Gruzieva</surname> <given-names>O</given-names></name><name><surname>Maguire</surname> <given-names>RL</given-names></name><name><surname>Gilliland</surname> <given-names>F</given-names></name><name><surname>Baïz</surname> <given-names>N</given-names></name><name><surname>Nohr</surname> <given-names>EA</given-names></name><name><surname>Corpeleijn</surname> <given-names>E</given-names></name><name><surname>Sebert</surname> <given-names>S</given-names></name><name><surname>Karmaus</surname> <given-names>W</given-names></name><name><surname>Grote</surname> <given-names>V</given-names></name><name><surname>Kajantie</surname> <given-names>E</given-names></name><name><surname>Magnus</surname> <given-names>MC</given-names></name><name><surname>Örtqvist</surname> <given-names>AK</given-names></name><name><surname>Eng</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>AH</given-names></name><name><surname>Kull</surname> <given-names>I</given-names></name><name><surname>Jaddoe</surname> <given-names>VWV</given-names></name><name><surname>Sunyer</surname> <given-names>J</given-names></name><name><surname>Kere</surname> <given-names>J</given-names></name><name><surname>Hoyo</surname> <given-names>C</given-names></name><name><surname>Annesi-Maesano</surname> <given-names>I</given-names></name><name><surname>Arshad</surname> <given-names>SH</given-names></name><name><surname>Koletzko</surname> <given-names>B</given-names></name><name><surname>Brunekreef</surname> <given-names>B</given-names></name><name><surname>Binder</surname> <given-names>EB</given-names></name><name><surname>Räikkönen</surname> <given-names>K</given-names></name><name><surname>Reischl</surname> <given-names>E</given-names></name><name><surname>Holloway</surname> <given-names>JW</given-names></name><name><surname>Jarvelin</surname> <given-names>M-R</given-names></name><name><surname>Snieder</surname> <given-names>H</given-names></name><name><surname>Kazmi</surname> <given-names>N</given-names></name><name><surname>Breton</surname> <given-names>CV</given-names></name><name><surname>Murphy</surname> <given-names>SK</given-names></name><name><surname>Pershagen</surname> <given-names>G</given-names></name><name><surname>Anto</surname> <given-names>JM</given-names></name><name><surname>Relton</surname> <given-names>CL</given-names></name><name><surname>Schwartz</surname> <given-names>DA</given-names></name><name><surname>Burchard</surname> <given-names>EG</given-names></name><name><surname>Huang</surname> <given-names>R-C</given-names></name><name><surname>Nystad</surname> <given-names>W</given-names></name><name><surname>Almqvist</surname> <given-names>C</given-names></name><name><surname>Henderson</surname> <given-names>AJ</given-names></name><name><surname>Melén</surname> <given-names>E</given-names></name><name><surname>Duijts</surname> <given-names>L</given-names></name><name><surname>Koppelman</surname> <given-names>GH</given-names></name><name><surname>London</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Epigenome-wide meta-analysis of DNA methylation and childhood asthma</article-title><source>Journal of Allergy and Clinical Immunology</source><volume>143</volume><fpage>2062</fpage><lpage>2074</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2018.11.043</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reich</surname> <given-names>D</given-names></name><name><surname>Nalls</surname> <given-names>MA</given-names></name><name><surname>Kao</surname> <given-names>WH</given-names></name><name><surname>Akylbekova</surname> <given-names>EL</given-names></name><name><surname>Tandon</surname> <given-names>A</given-names></name><name><surname>Patterson</surname> <given-names>N</given-names></name><name><surname>Mullikin</surname> <given-names>J</given-names></name><name><surname>Hsueh</surname> <given-names>WC</given-names></name><name><surname>Cheng</surname> <given-names>CY</given-names></name><name><surname>Coresh</surname> <given-names>J</given-names></name><name><surname>Boerwinkle</surname> <given-names>E</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Waliszewska</surname> <given-names>A</given-names></name><name><surname>Neubauer</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>R</given-names></name><name><surname>Leak</surname> <given-names>TS</given-names></name><name><surname>Ekunwe</surname> <given-names>L</given-names></name><name><surname>Files</surname> <given-names>JC</given-names></name><name><surname>Hardy</surname> <given-names>CL</given-names></name><name><surname>Zmuda</surname> <given-names>JM</given-names></name><name><surname>Taylor</surname> <given-names>HA</given-names></name><name><surname>Ziv</surname> <given-names>E</given-names></name><name><surname>Harris</surname> <given-names>TB</given-names></name><name><surname>Wilson</surname> <given-names>JG</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Reduced neutrophil count in people of african descent is due to a regulatory variant in the duffy antigen receptor for chemokines gene</article-title><source>PLOS Genetics</source><volume>5</volume><elocation-id>e1000360</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1000360</pub-id><pub-id pub-id-type="pmid">19180233</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rieber</surname> <given-names>N</given-names></name><name><surname>Gille</surname> <given-names>C</given-names></name><name><surname>Köstlin</surname> <given-names>N</given-names></name><name><surname>Schäfer</surname> <given-names>I</given-names></name><name><surname>Spring</surname> <given-names>B</given-names></name><name><surname>Ost</surname> <given-names>M</given-names></name><name><surname>Spieles</surname> <given-names>H</given-names></name><name><surname>Kugel</surname> <given-names>HA</given-names></name><name><surname>Pfeiffer</surname> <given-names>M</given-names></name><name><surname>Heininger</surname> <given-names>V</given-names></name><name><surname>Alkhaled</surname> <given-names>M</given-names></name><name><surname>Hector</surname> <given-names>A</given-names></name><name><surname>Mays</surname> <given-names>L</given-names></name><name><surname>Kormann</surname> <given-names>M</given-names></name><name><surname>Zundel</surname> <given-names>S</given-names></name><name><surname>Fuchs</surname> <given-names>J</given-names></name><name><surname>Handgretinger</surname> <given-names>R</given-names></name><name><surname>Poets</surname> <given-names>CF</given-names></name><name><surname>Hartl</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses</article-title><source>Clinical &amp; Experimental Immunology</source><volume>174</volume><fpage>45</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1111/cei.12143</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohatgi</surname> <given-names>A</given-names></name><name><surname>Ayers</surname> <given-names>CR</given-names></name><name><surname>Khera</surname> <given-names>A</given-names></name><name><surname>McGuire</surname> <given-names>DK</given-names></name><name><surname>Das</surname> <given-names>SR</given-names></name><name><surname>Matulevicius</surname> <given-names>S</given-names></name><name><surname>Timaran</surname> <given-names>CH</given-names></name><name><surname>Rosero</surname> <given-names>EB</given-names></name><name><surname>de Lemos</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The association between peptidoglycan recognition protein-1 and coronary and peripheral atherosclerosis: Observations from the Dallas Heart Study</article-title><source>Atherosclerosis</source><volume>203</volume><fpage>569</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2008.07.015</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rørvig</surname> <given-names>S</given-names></name><name><surname>Østergaard</surname> <given-names>O</given-names></name><name><surname>Heegaard</surname> <given-names>NHH</given-names></name><name><surname>Borregaard</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Proteome profiling of human neutrophil granule subsets, secretory vesicles, and cell membrane: correlation with transcriptome profiling of neutrophil precursors</article-title><source>Journal of Leukocyte Biology</source><volume>94</volume><fpage>711</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1189/jlb.1212619</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaub</surname> <given-names>B</given-names></name><name><surname>Tantisira</surname> <given-names>KG</given-names></name><name><surname>Gibbons</surname> <given-names>FK</given-names></name><name><surname>He</surname> <given-names>H</given-names></name><name><surname>Litonjua</surname> <given-names>AA</given-names></name><name><surname>Gillman</surname> <given-names>MW</given-names></name><name><surname>Weiss</surname> <given-names>S</given-names></name><name><surname>Perkins</surname> <given-names>DL</given-names></name><name><surname>Gold</surname> <given-names>DR</given-names></name><name><surname>Finn</surname> <given-names>PW</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Fetal Cord Blood: Aspects of Heightened Immune Responses</article-title><source>Journal of Clinical Immunology</source><volume>25</volume><fpage>329</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1007/s10875-005-4180-5</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmutz</surname> <given-names>N</given-names></name><name><surname>Henry</surname> <given-names>E</given-names></name><name><surname>Jopling</surname> <given-names>J</given-names></name><name><surname>Christensen</surname> <given-names>RD</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Expected ranges for blood neutrophil concentrations of neonates: the Manroe and Mouzinho charts revisited</article-title><source>Journal of Perinatology</source><volume>28</volume><fpage>275</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1038/sj.jp.7211916</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname> <given-names>PS</given-names></name><name><surname>Wegienka</surname> <given-names>G</given-names></name><name><surname>Havstad</surname> <given-names>S</given-names></name><name><surname>Johnson</surname> <given-names>CC</given-names></name><name><surname>Ownby</surname> <given-names>DR</given-names></name><name><surname>Zoratti</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The relationship between cord blood immunoglobulin E levels and allergy-related outcomes in young adults</article-title><source>Annals of Allergy, Asthma &amp; Immunology</source><volume>106</volume><fpage>245</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1016/j.anai.2010.12.006</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>CL</given-names></name><name><surname>Dickinson</surname> <given-names>P</given-names></name><name><surname>Forster</surname> <given-names>T</given-names></name><name><surname>Craigon</surname> <given-names>M</given-names></name><name><surname>Ross</surname> <given-names>A</given-names></name><name><surname>Khondoker</surname> <given-names>MR</given-names></name><name><surname>France</surname> <given-names>R</given-names></name><name><surname>Ivens</surname> <given-names>A</given-names></name><name><surname>Lynn</surname> <given-names>DJ</given-names></name><name><surname>Orme</surname> <given-names>J</given-names></name><name><surname>Jackson</surname> <given-names>A</given-names></name><name><surname>Lacaze</surname> <given-names>P</given-names></name><name><surname>Flanagan</surname> <given-names>KL</given-names></name><name><surname>Stenson</surname> <given-names>BJ</given-names></name><name><surname>Ghazal</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Identification of a human neonatal immune-metabolic network associated with bacterial infection</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>4649</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms5649</pub-id><pub-id pub-id-type="pmid">25120092</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soneson</surname> <given-names>C</given-names></name><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Robinson</surname> <given-names>MD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences</article-title><source>F1000Research</source><volume>4</volume><elocation-id>1521</elocation-id><pub-id pub-id-type="doi">10.12688/f1000research.7563.1</pub-id><pub-id pub-id-type="pmid">26925227</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stünkel</surname> <given-names>W</given-names></name><name><surname>Pan</surname> <given-names>H</given-names></name><name><surname>Chew</surname> <given-names>SB</given-names></name><name><surname>Tng</surname> <given-names>E</given-names></name><name><surname>Tan</surname> <given-names>JH</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Joseph</surname> <given-names>R</given-names></name><name><surname>Cheong</surname> <given-names>CY</given-names></name><name><surname>Ong</surname> <given-names>ML</given-names></name><name><surname>Lee</surname> <given-names>YS</given-names></name><name><surname>Chong</surname> <given-names>YS</given-names></name><name><surname>Saw</surname> <given-names>SM</given-names></name><name><surname>Meaney</surname> <given-names>MJ</given-names></name><name><surname>Kwek</surname> <given-names>K</given-names></name><name><surname>Sheppard</surname> <given-names>AM</given-names></name><name><surname>Gluckman</surname> <given-names>PD</given-names></name><name><surname>Holbrook</surname> <given-names>JD</given-names></name><collab>GUSTO Study Group</collab></person-group><year iso-8601-date="2012">2012</year><article-title>Transcriptome changes affecting hedgehog and cytokine signalling in the umbilical cord: implications for disease risk</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e39744</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0039744</pub-id><pub-id pub-id-type="pmid">22808055</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname> <given-names>A</given-names></name><name><surname>Tamayo</surname> <given-names>P</given-names></name><name><surname>Mootha</surname> <given-names>VK</given-names></name><name><surname>Mukherjee</surname> <given-names>S</given-names></name><name><surname>Ebert</surname> <given-names>BL</given-names></name><name><surname>Gillette</surname> <given-names>MA</given-names></name><name><surname>Paulovich</surname> <given-names>A</given-names></name><name><surname>Pomeroy</surname> <given-names>SL</given-names></name><name><surname>Golub</surname> <given-names>TR</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Mesirov</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szklarczyk</surname> <given-names>D</given-names></name><name><surname>Gable</surname> <given-names>AL</given-names></name><name><surname>Lyon</surname> <given-names>D</given-names></name><name><surname>Junge</surname> <given-names>A</given-names></name><name><surname>Wyder</surname> <given-names>S</given-names></name><name><surname>Huerta-Cepas</surname> <given-names>J</given-names></name><name><surname>Simonovic</surname> <given-names>M</given-names></name><name><surname>Doncheva</surname> <given-names>NT</given-names></name><name><surname>Morris</surname> <given-names>JH</given-names></name><name><surname>Bork</surname> <given-names>P</given-names></name><name><surname>Jensen</surname> <given-names>LJ</given-names></name><name><surname>Mering</surname> <given-names>CV</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D607</fpage><lpage>D613</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1131</pub-id><pub-id pub-id-type="pmid">30476243</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thavagnanam</surname> <given-names>S</given-names></name><name><surname>Fleming</surname> <given-names>J</given-names></name><name><surname>Bromley</surname> <given-names>A</given-names></name><name><surname>Shields</surname> <given-names>MD</given-names></name><name><surname>Cardwell</surname> <given-names>CR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A meta-analysis of the association between caesarean section and childhood asthma</article-title><source>Clinical &amp; Experimental Allergy</source><volume>38</volume><fpage>629</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2222.2007.02780.x</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tse</surname> <given-names>SM</given-names></name><name><surname>Gold</surname> <given-names>DR</given-names></name><name><surname>Sordillo</surname> <given-names>JE</given-names></name><name><surname>Hoffman</surname> <given-names>EB</given-names></name><name><surname>Gillman</surname> <given-names>MW</given-names></name><name><surname>Rifas-Shiman</surname> <given-names>SL</given-names></name><name><surname>Fuhlbrigge</surname> <given-names>AL</given-names></name><name><surname>Tantisira</surname> <given-names>KG</given-names></name><name><surname>Weiss</surname> <given-names>ST</given-names></name><name><surname>Litonjua</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Diagnostic accuracy of the bronchodilator response in children</article-title><source>Journal of Allergy and Clinical Immunology</source><volume>132</volume><fpage>554</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2013.03.031</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turan</surname> <given-names>N</given-names></name><name><surname>Ghalwash</surname> <given-names>MF</given-names></name><name><surname>Katari</surname> <given-names>S</given-names></name><name><surname>Coutifaris</surname> <given-names>C</given-names></name><name><surname>Obradovic</surname> <given-names>Z</given-names></name><name><surname>Sapienza</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>DNA methylation differences at growth related genes correlate with birth weight: a molecular signature linked to developmental origins of adult disease?</article-title><source>BMC Medical Genomics</source><volume>5</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.1186/1755-8794-5-10</pub-id><pub-id pub-id-type="pmid">22498030</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turturice</surname> <given-names>BA</given-names></name><name><surname>Ranjan</surname> <given-names>R</given-names></name><name><surname>Nguyen</surname> <given-names>B</given-names></name><name><surname>Hughes</surname> <given-names>LM</given-names></name><name><surname>Andropolis</surname> <given-names>KE</given-names></name><name><surname>Gold</surname> <given-names>DR</given-names></name><name><surname>Litonjua</surname> <given-names>AA</given-names></name><name><surname>Oken</surname> <given-names>E</given-names></name><name><surname>Perkins</surname> <given-names>DL</given-names></name><name><surname>Finn</surname> <given-names>PW</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>Perinatal bacterial exposure contributes to IL-13 aeroallergen response</article-title><source>American Journal of Respiratory Cell and Molecular Biology</source><volume>57</volume><fpage>419</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2017-0027OC</pub-id><pub-id pub-id-type="pmid">28443674</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turturice</surname> <given-names>BA</given-names></name><name><surname>McGee</surname> <given-names>HS</given-names></name><name><surname>Oliver</surname> <given-names>B</given-names></name><name><surname>Baraket</surname> <given-names>M</given-names></name><name><surname>Nguyen</surname> <given-names>BT</given-names></name><name><surname>Ascoli</surname> <given-names>C</given-names></name><name><surname>Ranjan</surname> <given-names>R</given-names></name><name><surname>Rani</surname> <given-names>A</given-names></name><name><surname>Perkins</surname> <given-names>DL</given-names></name><name><surname>Finn</surname> <given-names>PW</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>Atopic asthmatic immune phenotypes associated with airway Microbiota and airway obstruction</article-title><source>PLOS ONE</source><volume>12</volume><elocation-id>e0184566</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0184566</pub-id><pub-id pub-id-type="pmid">29053714</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turturice</surname> <given-names>BA</given-names></name><name><surname>Gold</surname> <given-names>DR</given-names></name><name><surname>Litonjua</surname> <given-names>AA</given-names></name><name><surname>Oken</surname> <given-names>E</given-names></name><name><surname>Rifas-Shiman</surname> <given-names>S</given-names></name><name><surname>Perkins</surname> <given-names>DL</given-names></name><name><surname>Finn</surname> <given-names>PW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Lower perinatal exposure to proteobacteria is an independent predictor of early childhood wheezing</article-title><source>Journal of Allergy and Clinical Immunology</source><volume>143</volume><fpage>419</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2018.06.051</pub-id><pub-id pub-id-type="pmid">30205188</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlen</surname> <given-names>M</given-names></name><name><surname>Oksvold</surname> <given-names>P</given-names></name><name><surname>Fagerberg</surname> <given-names>L</given-names></name><name><surname>Lundberg</surname> <given-names>E</given-names></name><name><surname>Jonasson</surname> <given-names>K</given-names></name><name><surname>Forsberg</surname> <given-names>M</given-names></name><name><surname>Zwahlen</surname> <given-names>M</given-names></name><name><surname>Kampf</surname> <given-names>C</given-names></name><name><surname>Wester</surname> <given-names>K</given-names></name><name><surname>Hober</surname> <given-names>S</given-names></name><name><surname>Wernerus</surname> <given-names>H</given-names></name><name><surname>Björling</surname> <given-names>L</given-names></name><name><surname>Ponten</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Towards a knowledge-based human protein atlas</article-title><source>Nature Biotechnology</source><volume>28</volume><fpage>1248</fpage><lpage>1250</lpage><pub-id pub-id-type="doi">10.1038/nbt1210-1248</pub-id><pub-id pub-id-type="pmid">21139605</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Votavova</surname> <given-names>H</given-names></name><name><surname>Dostalova Merkerova</surname> <given-names>M</given-names></name><name><surname>Fejglova</surname> <given-names>K</given-names></name><name><surname>Vasikova</surname> <given-names>A</given-names></name><name><surname>Krejcik</surname> <given-names>Z</given-names></name><name><surname>Pastorkova</surname> <given-names>A</given-names></name><name><surname>Tabashidze</surname> <given-names>N</given-names></name><name><surname>Topinka</surname> <given-names>J</given-names></name><name><surname>Veleminsky</surname> <given-names>M</given-names></name><name><surname>Sram</surname> <given-names>RJ</given-names></name><name><surname>Brdicka</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Transcriptome alterations in maternal and fetal cells induced by tobacco smoke</article-title><source>Placenta</source><volume>32</volume><fpage>763</fpage><lpage>770</lpage><pub-id pub-id-type="doi">10.1016/j.placenta.2011.06.022</pub-id><pub-id pub-id-type="pmid">21803418</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Votavova</surname> <given-names>H</given-names></name><name><surname>Dostalova Merkerova</surname> <given-names>M</given-names></name><name><surname>Krejcik</surname> <given-names>Z</given-names></name><name><surname>Fejglova</surname> <given-names>K</given-names></name><name><surname>Vasikova</surname> <given-names>A</given-names></name><name><surname>Pastorkova</surname> <given-names>A</given-names></name><name><surname>Tabashidze</surname> <given-names>N</given-names></name><name><surname>Topinka</surname> <given-names>J</given-names></name><name><surname>Balascak</surname> <given-names>I</given-names></name><name><surname>Sram</surname> <given-names>RJ</given-names></name><name><surname>Brdicka</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Deregulation of gene expression induced by environmental tobacco smoke exposure in pregnancy</article-title><source>Nicotine &amp; Tobacco Research</source><volume>14</volume><fpage>1073</fpage><lpage>1082</lpage><pub-id pub-id-type="doi">10.1093/ntr/ntr325</pub-id><pub-id pub-id-type="pmid">22355075</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>LH</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Lu</surname> <given-names>X</given-names></name><name><surname>Gupta</surname> <given-names>D</given-names></name><name><surname>Dziarski</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Human peptidoglycan recognition proteins require zinc to kill both gram-positive and gram-negative Bacteria and are synergistic with antibacterial peptides</article-title><source>The Journal of Immunology</source><volume>178</volume><fpage>3116</fpage><lpage>3125</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.5.3116</pub-id><pub-id pub-id-type="pmid">17312159</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenzel</surname> <given-names>SE</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Asthma phenotypes: the evolution from clinical to molecular approaches</article-title><source>Nature Medicine</source><volume>18</volume><fpage>716</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1038/nm.2678</pub-id><pub-id pub-id-type="pmid">22561835</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winckelmans</surname> <given-names>E</given-names></name><name><surname>Vrijens</surname> <given-names>K</given-names></name><name><surname>Tsamou</surname> <given-names>M</given-names></name><name><surname>Janssen</surname> <given-names>BG</given-names></name><name><surname>Saenen</surname> <given-names>ND</given-names></name><name><surname>Roels</surname> <given-names>HA</given-names></name><name><surname>Kleinjans</surname> <given-names>J</given-names></name><name><surname>Lefebvre</surname> <given-names>W</given-names></name><name><surname>Vanpoucke</surname> <given-names>C</given-names></name><name><surname>de Kok</surname> <given-names>TM</given-names></name><name><surname>Nawrot</surname> <given-names>TS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Newborn sex-specific transcriptome signatures and gestational exposure to fine particles: findings from the ENVIRONAGE birth cohort</article-title><source>Environmental Health</source><volume>16</volume><elocation-id>52</elocation-id><pub-id pub-id-type="doi">10.1186/s12940-017-0264-y</pub-id><pub-id pub-id-type="pmid">28583124</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>XF</given-names></name><name><surname>Li</surname> <given-names>YJ</given-names></name><name><surname>Sheng</surname> <given-names>YJ</given-names></name><name><surname>Liu</surname> <given-names>JL</given-names></name><name><surname>Tang</surname> <given-names>LF</given-names></name><name><surname>Chen</surname> <given-names>ZM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Effect of low birth weight on childhood asthma: a meta-analysis</article-title><source>BMC Pediatrics</source><volume>14</volume><elocation-id>275</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2431-14-275</pub-id><pub-id pub-id-type="pmid">25339063</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>CJ</given-names></name><name><surname>Söderhäll</surname> <given-names>C</given-names></name><name><surname>Bustamante</surname> <given-names>M</given-names></name><name><surname>Baïz</surname> <given-names>N</given-names></name><name><surname>Gruzieva</surname> <given-names>O</given-names></name><name><surname>Gehring</surname> <given-names>U</given-names></name><name><surname>Mason</surname> <given-names>D</given-names></name><name><surname>Chatzi</surname> <given-names>L</given-names></name><name><surname>Basterrechea</surname> <given-names>M</given-names></name><name><surname>Llop</surname> <given-names>S</given-names></name><name><surname>Torrent</surname> <given-names>M</given-names></name><name><surname>Forastiere</surname> <given-names>F</given-names></name><name><surname>Fantini</surname> <given-names>MP</given-names></name><name><surname>Carlsen</surname> <given-names>KCL</given-names></name><name><surname>Haahtela</surname> <given-names>T</given-names></name><name><surname>Morin</surname> <given-names>A</given-names></name><name><surname>Kerkhof</surname> <given-names>M</given-names></name><name><surname>Merid</surname> <given-names>SK</given-names></name><name><surname>van Rijkom</surname> <given-names>B</given-names></name><name><surname>Jankipersadsing</surname> <given-names>SA</given-names></name><name><surname>Bonder</surname> <given-names>MJ</given-names></name><name><surname>Ballereau</surname> <given-names>S</given-names></name><name><surname>Vermeulen</surname> <given-names>CJ</given-names></name><name><surname>Aguirre-Gamboa</surname> <given-names>R</given-names></name><name><surname>de Jongste</surname> <given-names>JC</given-names></name><name><surname>Smit</surname> <given-names>HA</given-names></name><name><surname>Kumar</surname> <given-names>A</given-names></name><name><surname>Pershagen</surname> <given-names>G</given-names></name><name><surname>Guerra</surname> <given-names>S</given-names></name><name><surname>Garcia-Aymerich</surname> <given-names>J</given-names></name><name><surname>Greco</surname> <given-names>D</given-names></name><name><surname>Reinius</surname> <given-names>L</given-names></name><name><surname>McEachan</surname> <given-names>RRC</given-names></name><name><surname>Azad</surname> <given-names>R</given-names></name><name><surname>Hovland</surname> <given-names>V</given-names></name><name><surname>Mowinckel</surname> <given-names>P</given-names></name><name><surname>Alenius</surname> <given-names>H</given-names></name><name><surname>Fyhrquist</surname> <given-names>N</given-names></name><name><surname>Lemonnier</surname> <given-names>N</given-names></name><name><surname>Pellet</surname> <given-names>J</given-names></name><name><surname>Auffray</surname> <given-names>C</given-names></name><name><surname>van der Vlies</surname> <given-names>P</given-names></name><name><surname>van Diemen</surname> <given-names>CC</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Wijmenga</surname> <given-names>C</given-names></name><name><surname>Netea</surname> <given-names>MG</given-names></name><name><surname>Moffatt</surname> <given-names>MF</given-names></name><name><surname>Cookson</surname> <given-names>W</given-names></name><name><surname>Anto</surname> <given-names>JM</given-names></name><name><surname>Bousquet</surname> <given-names>J</given-names></name><name><surname>Laatikainen</surname> <given-names>T</given-names></name><name><surname>Laprise</surname> <given-names>C</given-names></name><name><surname>Carlsen</surname> <given-names>KH</given-names></name><name><surname>Gori</surname> <given-names>D</given-names></name><name><surname>Porta</surname> <given-names>D</given-names></name><name><surname>Iñiguez</surname> <given-names>C</given-names></name><name><surname>Bilbao</surname> <given-names>JR</given-names></name><name><surname>Kogevinas</surname> <given-names>M</given-names></name><name><surname>Wright</surname> <given-names>J</given-names></name><name><surname>Brunekreef</surname> <given-names>B</given-names></name><name><surname>Kere</surname> <given-names>J</given-names></name><name><surname>Nawijn</surname> <given-names>MC</given-names></name><name><surname>Annesi-Maesano</surname> <given-names>I</given-names></name><name><surname>Sunyer</surname> <given-names>J</given-names></name><name><surname>Melén</surname> <given-names>E</given-names></name><name><surname>Koppelman</surname> <given-names>GH</given-names></name><collab>BIOS Consortium</collab></person-group><year iso-8601-date="2018">2018</year><article-title>DNA methylation in childhood asthma: an epigenome-wide meta-analysis</article-title><source>The Lancet. Respiratory Medicine</source><volume>6</volume><fpage>379</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(18)30052-3</pub-id><pub-id pub-id-type="pmid">29496485</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname> <given-names>X</given-names></name><name><surname>Gao</surname> <given-names>M</given-names></name><name><surname>Dai</surname> <given-names>C</given-names></name><name><surname>Meyer</surname> <given-names>KS</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Keeran</surname> <given-names>KJ</given-names></name><name><surname>Nugent</surname> <given-names>GZ</given-names></name><name><surname>Qu</surname> <given-names>X</given-names></name><name><surname>Yu</surname> <given-names>ZX</given-names></name><name><surname>Dagur</surname> <given-names>PK</given-names></name><name><surname>McCoy</surname> <given-names>JP</given-names></name><name><surname>Levine</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Peptidoglycan recognition protein 1 promotes house dust mite-induced airway inflammation in mice</article-title><source>American Journal of Respiratory Cell and Molecular Biology</source><volume>49</volume><fpage>902</fpage><lpage>911</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2013-0001OC</pub-id><pub-id pub-id-type="pmid">23808363</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>Y</given-names></name><name><surname>Gong</surname> <given-names>K</given-names></name><name><surname>Denholtz</surname> <given-names>M</given-names></name><name><surname>Chandra</surname> <given-names>V</given-names></name><name><surname>Kamps</surname> <given-names>MP</given-names></name><name><surname>Alber</surname> <given-names>F</given-names></name><name><surname>Murre</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Comprehensive characterization of neutrophil genome topology</article-title><source>Genes &amp; Development</source><volume>31</volume><fpage>141</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1101/gad.293910.116</pub-id><pub-id pub-id-type="pmid">28167501</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63745.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Reviewing Editor</role><aff><institution>Icahn School of Medicine at Mount Sinai</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Keane</surname><given-names>Michael</given-names> </name><role>Reviewer</role><aff><country>Ireland</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This study documents that the abundance of neutrophil specific granules at birth predicts the risk for pediatric asthma and reduced pulmonary function. The authors have used existing transcriptomic data from cord blood mononuclear cells, and have shown an inverse correlation between myeloid differentiation and the risk of pediatric asthma. This gene set was validated in an independent cohort and was found to contain associated genes localizing to neutrophil specific granules. Specifically, PGLYRP-1, a granule protein, was inversely associated with mid-childhood current asthma.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Perinatal Granulopoiesis and Risk of Pediatric Asthma&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by Mone Zaidi as the Senior and Reviewing Editor. The following individual involved in review of your submission has agreed to reveal their identity: Michael Keane (Reviewer #3).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>This is a nice study that is clearly written and makes use of several datasets. It attempts to explain perinatal risk factors and the associated risk of developing pediatric asthma in the mid-childhood and early teenage years. Identified among maternal characteristics that were associated with risks of subsequent asthma development included atopy, BMI, race/ethnicity and demographics, birth characteristics, and mode of delivery. The paper then goes on to demonstrate the differences in immune response during the different time frames of pregnancy. Most notably, a gene signature associated with increased myelopoiesis in utero is associated with increased risk of pediatric asthma. Furthermore they show that cord blood serum PGLYRP -1 is associated with reduced risk of pediatric asthma and increased FEV1/FVC. Interestingly sIL6ra which is derived from neutrophils but not associated with neutrophil granules did not show any association with pulmonary outcomes. This suggests that it is the neutrophil granules rather than the neutrophils per se that are the problem association. The following should be addressed</p><p>Essential revisions:</p><p>1) Please readjust the Introduction; a lot of emphasis is placed on IFN/infection/asthma, but after this fact, it seems neglected. Furthermore, while the manuscript is clearly written, the message regarding PGLYRP-1 is at times confusing. There is clarity that PGLYRP -1 is inversely associated with mid childhood asthma risk. The Discussion however refers to animal models where PGLYRP -1 is proinflammatory and is associated with increased airway resistance and allergen sensitization. The apparent disparity should be clarified.</p><p>2) The take-home message for the paper – that there appears to be an inverse relationship between serum levels of PGLYRP-1 and overall risk for pediatric asthma – should be explored in relation to whether a predictive role for such proteins is possible since the authors can accurately predict risk factors for disease and assess pulmonary function. Other proteins, like the sIL6Ra, have no association with disease predictability and have no association with predicting pulmonary outcomes. This should be explored/explained in greater detail.</p><p>3) As part of the validation efforts of the study – the rationale for using three different cohorts to assess pediatric asthma risk was not clearly explained.</p><p>4) In terms of correlations between each protein level and pulmonary function – the sIL6Ra protein was not associated with the FEV1/FVC ratio or a bronchodilator response at either age group. However, it was found that increased levels of PGLYRP-1 were associated with an increased FEV1/FVC ratio (not indicative of asthma) and reduced odds of developing pediatric asthma at each age group. This analysis makes sense as increased production of neutrophil granules, PGLYRP-1, serves a protective effect against infection, reducing incidence of disease states. The paper, however, should explore the rationale behind the no-response to the sIL6Ra protein. In terms of understanding, since this protein is NOT associated with neutrophilic granules, it can be inferred, that is it may not have a role in protecting against infection. However, this could have been explored in more detail in the paper.</p><p>5) What is the proposed role of neutrophil degranulation in the pathogenesis or long term susceptibility to asthma?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63745.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Please readjust the Introduction; a lot of emphasis is placed on IFN/infection/asthma, but after this fact, it seems neglected. Furthermore, while the manuscript is clearly written, the message regarding PGLYRP-1 is at times confusing. There is clarity that PGLYRP -1 is inversely associated with mid childhood asthma risk. The Discussion however refers to animal models where PGLYRP -1 is proinflammatory and is associated with increased airway resistance and allergen sensitization. The apparent disparity should be clarified.</p></disp-quote><p>We have edited the Introduction in response to the reviewer comments. We focus on known variability in the neonatal immune system that is associated with either asthma or perinatal risk factors for asthma. We have removed paragraphs regarding relationships between IFN and infection.</p><p>We have further edited and expanded our Discussion with regards to confusion concerning the role of PGLYRP-1 in asthma pathology. We indicated the relevance the murine <italic>pglyrp-1</italic><sup>-/-</sup> studies even though the methodologies of the studies limit the contextualization between those studies and ours. The murine studies have demonstrated a role for PGLYRP-1 in enhancing T2 airway inflammation in adult mice at the time of insult. Yet, these studies due to their methodologies have not been able to examine the impact of early life variation in PGLYRP-1 and its impact on asthma development. This highlights the temporal role of PGLYRP-1 in asthma which we have outlined in the Discussion.</p><disp-quote content-type="editor-comment"><p>2) The take-home message for the paper – that there appears to be an inverse relationship between serum levels of PGLYRP-1 and overall risk for pediatric asthma – should be explored in relation to whether a predictive role for such proteins is possible since the authors can accurately predict risk factors for disease and assess pulmonary function. Other proteins, like the sIL6Ra, have no association with disease predictability and have no association with predicting pulmonary outcomes. This should be explored/explained in greater detail.</p></disp-quote><p>In our revised Discussion, we have expanded upon the analyses of PGLYRP-1 and sIL6Rα. To reiterate, PGLYRP-1 is consistently associated with perinatal risk factors for asthma across cohorts and analyses, whereas sIL6Rα is not. Further, the stronger association between sIL6Rα, Black/African-American maternal race, and neutrophil abundance in CyTOF highlights that sIL6Rα is likely more reflective of absolute neutrophil count in cord blood. PGLYRP-1 is more associated with one aspect of functional diversity, secondary granule abundance, in neutrophils at birth which we had identified as a potential risk predictor for asthma through our meta-analysis. sIL6Rα was measured as a control and not expected to be associated with pulmonary outcomes. We have also detailed this rationale in our revised Results and Discussion.</p><disp-quote content-type="editor-comment"><p>3) As part of the validation efforts of the study – the rationale for using three different cohorts to assess pediatric asthma risk was not clearly explained.</p></disp-quote><p>We refer the reviewers to the Results section which state our rationale for the inclusion of each cohort. Specifically, we have detailed how each dataset cohort allows for examination of associations between either demographics or outcomes and various biologic components (mRNA, cells, serum proteins). Further, we underscore that we are able to reproducibly show the association of PGLYRP-1 with perinatal risk factors in each cohort and within our meta-analysis which advances the generalizability of our findings.</p><disp-quote content-type="editor-comment"><p>4) In terms of correlations between each protein level and pulmonary function – the sIL6Ra protein was not associated with the FEV1/FVC ratio or a bronchodilator response at either age group. However, it was found that increased levels of PGLYRP-1 were associated with an increased FEV1/FVC ratio (not indicative of asthma) and reduced odds of developing pediatric asthma at each age group. This analysis makes sense as increased production of neutrophil granules, PGLYRP-1, serves a protective effect against infection, reducing incidence of disease states. The paper, however, should explore the rationale behind the no-response to the sIL6Ra protein. In terms of understanding, since this protein is NOT associated with neutrophilic granules, it can be inferred, that is it may not have a role in protecting against infection. However, this could have been explored in more detail in the paper.</p></disp-quote><p>This reviewer comment is similar to the point raised in major concern 2. Please see our comment in response to major concern 2, as it address both concerns.</p><disp-quote content-type="editor-comment"><p>5) What is the proposed role of neutrophil degranulation in the pathogenesis or long term susceptibility to asthma?</p></disp-quote><p>Our objective was to identify biological pathways that are modulated by multiple risk factors to predict asthma in this observational study. We have stated that the lack of mechanism(s) due is a limitation in our Discussion. While investigated this mechanistic role(s) is of interest, it is beyond the scope of this study. We have discussed potential functional roles that PGLYRP-1 might play in early life immunity, but we refrain from proposing broader roles in asthma pathogenesis as this would be speculation.</p></body></sub-article></article>